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Solid-phase immunoassays (SPIs) have become an indispensible tool for research, 
diagnostics, and therapeutics.  Understanding the antibody-antigen interaction occurring 
at a solid-liquid interface is needed in order to develop more sensitive and selective 
sensors with lower limits of detection.  In turn, this will provide a better understanding of 
the immune system, and lead to the discovery of more effective immunotherapy 
treatments.  In this work, total internal reflection fluorescence (TIRF) microscopy is 
employed to investigate individual ligand-receptor interactions at a glass-water interface.  
The extreme sensitivity of TIRF imaging requires the measurement surfaces to resist the 
nonspecific adsorption of proteins in order to minimize backgrounds, while containing 
low density of optically resolvable capture sites.  The nonspecific adsorption of 
antibodies to poly(ethylene glycol) (PEG) monolayers covalently bound to glass surfaces 
was characterized for two different PEG immobilization procedures. First, N-
hydroxysuccinimide (NHS) active esters of 2000 g/mol PEG were reacted to the amine 
functionality of (3-aminopropyl)triethoxysilane (APTES) derivatized glass slides; 
secondly, in addition, 750 g/mol and 2000 g/mol PEG-amines were reacted to the 
epoxide functionality of (3-Glycidyloxypropyl)trimethoxysilane (GOPTS) modified glass 
slides.  The protein resistant property of each PEG-modified surface was characterized by 
monitoring the adsorption of monoclonal mouse derived antibiotin using single-molecule 
 iv 
fluorescence imaging.  The protein resistant coating produced using epoxide-amine PEG 
chemistry was adapted to produce a glass modified surface containing a low density of 
biotin conjugation sites by reacting a mixture containing a lower concentration of biotin-
labeled 2000 g/mol PEG-amine and a higher concentration of 750 g/mol PEG-amine to 
GOPTS modified glass slides.  The density of biotin conjugation sites within the diluent 
PEG layer was characterized using fluorescently-labeled streptavidin, where the surface 
concentration of biotin increased linearly with biotin-PEG concentration in the reaction 
solution.  Using the low density biotin capture surfaces, the activity of a surface 
immobilized rabbit-antigoat IgG receptor was investigated using TIRF imaging for four 
different antibody immobilization strategies: (i) passive adsorption to the mPEG surface, 
(ii) active bioaffinity immobilization directly to streptavidin capture sites, (iii) two-step 
sequential immobilization of streptavidin and protein A intermediate, and





















“I prefer to be true to myself, even at the hazard of incurring the ridicule of others, rather 
than to be false, and to incur my own abhorrence.” 
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Antibodies consist of a variety of globular proteins referred to as 
immunoglobulins that are contained within the plasma and extracellular fluids of 
vertebrates.  Incredibly diverse in their ability to selectively recognize and bind specific 
epitopes of proteins, antibodies aid in the recognition and destruction of foreign invaders 
such as bacteria and viruses, known as antigens.
1
 Besides serving as one of the principal 
effectors of the adaptive immune system, antibodies have also been extensively used in 




 and therapeutic purposes.
5
 The goal of 
this dissertation is to develop tools to characterize individual antibody-antigen 
interactions at the single-molecule level.  This technology could eventually produce more 
sensitive and selective immunosensors, provide a better understanding of the immune 
system, and lead to the discovery of more effective immunotherapy treatments.  
Biological science has long since been confronted with numerous challenges to 
develop in vitro models that accurately depict in vivo processes.  The majority of the 
active antibodies within living organisms act in concert with cell membranes, carrying 
out their molecular recognition functions at membrane interfaces.
1 




reaction conditions have commonly been employed to measure a host of antibody-antigen 
interactions in vitro.  In fact, it has been documented that the kinetics of cell surface-
antibody interactions are more accurately represented by solid-phase antibody-antigen 
measurements than those observed in free solution;
6,7 
however, the direct comparison of 
in vivo cell-membrane receptor-ligand interactions with in vitro solid-phase receptor-
ligand interactions neglects to account for significant differences between the properties 
of the two interfaces.  Solid-phase surfaces are rigid and chemically fixed unlike the 
dynamic fluidity exhibited by living membranes, a property that has been shown to 
contribute to membrane-associated protein-protein interactions.
8,9
 As a result, in vitro 
solid-phase receptor-ligand interactions are often times perturbed by intrinsic surface 
properties associated with the measurement platform, including transport limitations, 
restricted reaction volumes, steric interactions between densely packed receptor 
molecules, structural changes within surface immobilized protein-receptor molecules, and 
the orientation of surface-immobilized receptor molecules.
10-14 
Interfacial antibody-antigen interactions have been characterized using a variety 









 and quartz crystal microbalance (QCM).
25-27
 Each of these 
techniques measures average signals that reveal little information about the 
heterogeneity, for multistep capture assays, and the molecular history of individual 
receptor sites.  In addition, such methods often require a high density of receptor surface 
sites in order to achieve detectable signals, which results in transport limitations and 
crowding effects that perturb reaction kinetics.
28
 In order to minimize such effects, the 
density of receptor sites needs to be reduced to very low fractions (<10
-4




(~50 kDa) monolayer; however, this requires an extremely sensitive measurement 
technique capable of resolving single-molecules at an interface.  
In order to image single receptor sites, it is necessary to probe small volumes near 
the measurement interface, while rejecting background signal from the bulk solution.  
Total internal reflection fluorescence (TIRF) imaging accomplishes these requirements 
by producing a nonpropagating evanescent wave that only excites fluorescently labeled 
ligand-molecules contained within the first ~150 nm from a glass/water interface.  
Although background fluorescence from solution is reduced using this technique, the 
sensitivity of such measurements requires that the surface resist the nonspecific 
adsorption of proteins, while containing a low density of receptor sites in order to resolve 
specific single-molecule events.  When combined with TIRF imaging, such surfaces 
would allow individual interfacial ligand-receptor interactions to be investigated, where 
the heterogeneity from site-to-site and the capture history of individual sites for multi-
step capture assays could be characterized.  
 
1.2 Immunoglobulin G Structure 
Secreted by B lymphocytes (plasma cells), antibodies are glycoproteins belonging 
to a family of globular proteins known as immunoglobulins (Ig), which aid in the 
immune response against antigens within living vertabrates.  Gamma-globulins (IgG), 
commonly used in solid-phase immunoassays, are composed of two identical halves, both 
of which contain a heavy (~55 kDa) and light (~25 kDa) polypeptide chain held together 
by disulfide linkages and electrostatic interactions.  The resulting tetrameric-quaternary 








Figure 1.1: Structure of the immunoglobulin G (IgG) antibody 
molecule.  Composed of two identical halves, both of which contain a 
light polypeptide chain (~25 kDa) and the heavy polypetide chain 
(~55 kDa) held together by disulfide linkages and electrostatic 
interactions.  Each of the identical Fab (varible) domains can 
independently bind an individual antigen.  The Fc (constant) region 




shape.  The IgG molecule is composed of three fragments all connected, through multiple 
disulfide linkages, at the center of the “Y,” known as the hinge region, giving the 
antibody dynamic flexibility.  Having two identical fragments, known as the variable 
domains (Fab), that are responsible for the binding antigens, the IgG is bivalent, capable 
of binding two antigens at once.  The amino acid sequences that compose the two 
identical Fab domains vary from IgG-to-IgG, giving each clone of IgG molecules the 
ability to bind specific, yet different antigens.  The third fragment of the IgG molecule, 
referred to as the constant region (Fc), is nearly conserved from clone-to-clone of IgG 
molecules, and the primary function of the Fc region is to aid in effector functions.
1,29
      
 
1.3 Solid Phase Immunoassays and Interfacial Protein Activity 
Landsteiner first presented the concept of the immunoassay in 1945 by 
demonstrating small molecules (haptens) could illicit an immune response when 
conjugated to larger carrier molecules;
30
 however, it was not utilized until the late 1950s 
when Yalow and Berson reported on the first radioimmunoassay (RIA).  Using 
131
I-
labeled insulin, Yalow and Berson were able to measure the concentration of insulin in 
human serum establishing the first competitive immunoassay.
31
 In such assays, the 
analyte-antigen competes with a known concentration of 
131
I-labeled antigen for 
homologous antibodies. At equilibrium, the ratio of free-to-bound 
131
I-labeled antigen is 
directly proportional to the concentration of total antigen in solution; however, measuring 
this ratio requires that the free antigen be separated from the bound antigen-antibody 
complex, which is a slow and cumbersome process.  




Catt and Tregear developed the solid-phase immunoassay (SPI) in the late 1960s.
32
 The 
fundamental principle behind the SPI utilizes surface-immobilized capture antibodies 
(receptor) to selectively bind antigens from free solution (ligand).  After equilibrium has 
been established, the unbound antigen is simply rinsed from the surface, leaving only 
those antigens captured by interfacially immobilized antibodies.  Since their introduction, 
SPIs have undergone a variety of permutations and improvements, while maintaining the 
original fundamental principles.  Today, SPIs have been interfaced with a variety of 
analytical techniques, including electrochemical,
33-35
 quartz crystal microbalance 
(QCM),
25,36









 and agricultural diagnostics.
4,45
  
The specific binding of ligands to surface-immobilized receptor sites commonly 
exhibits reactivities that differ greatly from the equivalent interaction observed in free 
solution.  The measured reaction rates for ligand-receptor complexation at a solid-liquid 
interface are often times convoluted with mass transport effects resulting from diffusion 
to the surface, restricted reaction volumes,
8,46
 and the surface density of the receptor 
sites.
7
 Because the receptor molecule is directly immobilized to the interface in 
heterogeneous assays, the true reaction volume is confined within the attractive distance 
of the strongest electrostatic, Van der Waals, or hydrophobic interactions occurring 
between free-solution ligand and immobilized receptor.  This is confined to  ~10-100 Å 
from the receptor.
8,14
   The time required for diffusion to bring ligands into these reaction 
volumes in sufficient numbers to satisfy a significant fraction of the receptors on the 
surface can cause the measured binding rates to be transport limited,
46-48
 as is discussed 





In addition to the observed forward reaction rate often being mass transport 
limited, the antibody-antigen reactions at a solid-liquid interface often generally do not 
exhibit reversible kinetics.  It has been demonstrated both theoretically and 
experimentally that once bound, antibody-antigen complexes at surfaces are stabilized 
and rarely dissociate.
7,49,50
 It has been reported that the Langmuir-like kinetics observed 
for an interfacial antibody-antigen binding isotherm are the result of concentration-
dependent saturation levels and not dynamic equilibria.
19
 Currently there are two possible 
explanations as to why the interfacial antibody-antigen complex appears to be irreversible 
(see Figure 1.2). First, at a high surface concentration of an immobilized antigen or 
hapten receptor, it may be possible that the bivalency of an antibody-ligand interaction 
allows both antigen-binding sites to be simultaneously bound to multiple, closely spaced 
receptor molecules.  This could also be true for a multivalent receptor site binding 
multiple epitopes of a single antigen.  As a result, the probability of both binding sites 
dissociating is vanishingly small, so that the ligand cannot escape the surface. Secondly, 
if dissociation does occur, diffusion must carry the ligand away from the surface.  For a 
high density of receptor sites, it has been hypothesized that transport away from a surface 
may not compete efficiently with the recapture by surface receptors, so that unbound 
ligands are unable to reach the stirred boundary layer, where flowing solution actively 
carries them downstream from the area of observation.
19,49
 It has been well documented 
that the unbinding of a ligands from a capture surface can be an extremely slow process; 
however, the mechanisms explaining the slow off rates observed in SPIs are only 
hypothesized and have not verified by direct observations. 





Figure 1.2: Hypothesized source of irreversible kinetics associated with the 
interaction of a ligand with a specific surface receptor site, while this figure 
specifically demonstrates the binding of an antibody-ligand to an antigen-
receptor, the situation is also applicable to closely spaced multivalent receptor 
sites capturing multiple epitopes of an antigen-ligand.  (a) Bivalent interactions 
with closely spaced receptor sites prevent dissociation.  (b) Transport away 
from the surface may not efficiently compete with the recapture of ligand to 
receptor so that unbound ligands are unable to reach the unstirred boundary 
layer (gray dotted line), where flowing solution actively carries them 










antigen interactions, it is also well known that capture antibodies immobilized to solid 
surfaces exhibit decreased bioactivities compared to those measured in free solution.
16,51
 
Butler and coworkers reported that >90% of monoclonal antibodies immobilized to a 
polystyrene interface are rendered inactive and incapable of capturing solution-phase 
ligand molecules.
52 
It is believed that the orientation and configuration of the 
immobilized capture antibodies with respect to the interface are responsible for the 
decreased activity.
27,52-54
 There have been many attempts to increase the surface activity 
of capture antibodies by immobilizing them in specific orientations that promote access 
to the Fab domains to solution.  Strategies for oriented immobilization of antibodies 
include the use of intermediate immunoglobulins,
55
 Fc binding proteins such as protein A 
and protein G,
56-60
 and disulfide linkages.
61-63
 In many cases, capture antibodies 
immobilized to solid surfaces in an orientation that promotes the accessibility of the 
binding domain(s) have shown a significant increase in bioactivity; however, these 
methods commonly fail to achieve free solution-like activity or reversibility.
21
 
From these observations, it is clear that interfacial measurements of antigen-
antibody activity are quite complex.  In order to achieve an SPI that accurately represents 
in vivo interactions, the processes that govern the unique kinetics and decreased activities 
associated with in vitro interfacial interactions must be better understood.  This goal 
could be advanced by querying interfacial-receptor activities at an individual receptor-
ligand level.  To our knowledge, nothing has been reported on characterizing and 
understanding the activities of individual ligand-receptor interactions commonly 
associated with SPIs at the single-molecule level.  By using single-molecule imaging, the 




understand interfacial ligand-receptor interactions.   
 
1.4 Mass Transport 
As illustrated in Figure 1.3, transport limitations in surface-binding reactions are 
the result of the interfacial-ligand concentration gradient that develops upon depletion of 
ligand molecules captured by receptor sites.  The depletion layer (ls) is the distance into 
solution that contains the number of ligand molecules needed to provide half of the 
immobilized receptor sites with a ligand molecule.  For a surface concentration of 
receptor sites, R in cm
-2
, which would be, for example, half-occupied by ligands upon 
reaction from a solution of concentration, [L] in mols/cm
3
, the depletion layer thickness 





                                                       (1.1) 
 
where Na is Avogadro’s number.  The time, τs, required to relax this concentration 
gradient, through diffusion to the surface, is given by: 
 




                                                          (1.2) 
 








 For a ligand 
concentration in solution of [L] = 1 × 10
-9
 M, and for a typical capture surface used in 













Figure 1.3: Transport limitations in the surface-binding reaction for a 
high density (left) and low density (right) of receptor surface sites 
(blue circles) to 0.5 coverage of ligand (purple semicircles).  The red 
dotted line represents the depletion layer, ls, the distance into solution 
that contains the number of ligands to provide 0.5 of the receptor sites 































depletion layer, ls, would be ~8 cm and would require ~4 years to satisfy the half-
coverage coverage of R by diffusion.  In contrast, using the density capture surfaces 





depletion layer, ls, would extend only ~0.8 μm from the surface and require just ~10 ms 
to relax the concentration gradient, τ, by diffusion   
 Flowing the solution over the surface is commonly used to overcome transport 
limitations associated with high-density capture surfaces.  In the case where flow is used, 
molecules must still diffuse to the surface through an unstirred boundary of thickness, Δx, 








                                                   (1.3) 
 
The time required in the presence of flow to relax the concentration gradient for half-
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, and an unstirred 
boundary layer thickness typical of very fast flow, Δx, 10 μm,66 then the time required to 




, capture surface 





is not needed to speed up the mass transport rate since ls << Δx ~ 10 μm; therefore, τflow = 




flow does not eliminate transport limitations.  This demonstrates the important influence 
that the surface density of capture sites has on the observed kinetics associated with 
interfacial ligand-receptor interactions. 
 
1.5 Surface Modification and Passivation 
Proteins are composed of a variety of functionalities that cause them to readily 
adsorb onto glass substrates through Van der Waals, Lewis acid-base, electrostatic, and 
hydrophobic forces.
67
 Often times upon adsorption to an interface, changes within the 
secondary and tertiary structures of the protein can lead to protein denaturation and 
decreased bioactivity.
68-70
 To improve the efficacy of SPIs and observe protein-protein 
interactions that approach their in vivo activities, the solid-liquid interface must not only 
provide resistance to the nonspecific adsorption of biomolecules, but must also allow 
surface immobilized capture proteins to maintain native-like conformations and activities.  
One of the most common and versatile methods to functionalizing glass surfaces, 
for use in biocompatible processes, has been through the use of silane chemistry.
71,72
 
Trifunctional alkoxy- or chloro-silanes monolayers are generally deposited onto glass 
surfaces using solution phase methods; however, such silanes are highly susceptible to 
oligomerization in the presence of water, and thus require the use of extremely dry 
solvents to prevent aggregation and formation of defects within the deposited monolayer 
during the reaction process.
73-76
 Even trace levels of water in the reaction solvents can 
result in the deposition of nonuniform multilayers, codeposition of aggregated silanes, 
and the hydrolytic stripping of predeposited silanes.
76-79
 Although less common than 




silanes onto glass-type substrates has been used as an efficient means to produce thin, 
uniform, and defect free functional monolayers.
76,77,80
 The differences between solution-
phase- and chemical-vapor- deposition techniques are illustrated in Figure 1.4.  
Thin films produced from CVD techniques have been characterized using x-ray- 
photoelectron-spectroscopy (XPS), contact-angle-goniometry, spectroscopic-
ellipsometry, atomic force microscopy (AFM), scanning-electron-microscopy (SEM), 
and time-of-flight-secondary-ion-mass-spectroscopy (ToF-SIMS).
75,77,81
 Two commonly 
employed silane reagents, (3-Glycidyloxypropyl)trimethoxysilane (GOPTS) and (3-
aminopropyl)triethoxysilane (APTES) have been deposited onto glass-type surfaces to 
prepare  epoxide and amine functionalized coatings.  These simple functionalities provide 
an extremely versatile means to further derivatized glass surfaces for a variety of 
applications, some of which are demonstrated in Figure 1.5.  
Poly(ethylene glycol) (PEG) molecules are often grafted onto a variety of 
substrates at high densities as a means to prevent the nonspecific adsorption of 
proteins.
82-86
 Owing to the large exclusion volumes and high degree of conformational 
mobility associated with PEG molecules, grafted PEG chains are highly resistant to 
biofouling;
87,88
 however, depending on the density and molecular weight of the grafted 
PEG monolayer, their adsorption-resistant properties vary greatly.
89,90
 In addition to the 
reduced protein adsorption, PEG monolayers have been shown to help surface-tethered 
proteins maintain more native-like conformations.
85
 By depositing a mixture of biotin- 
functionalized PEG (biotin-PEG) and mPEG molecules, receptor proteins can easily be 
immobilized to the resulting monolayers through streptavidin intermediates.
91,92
 In 







Figure 1.4: Comparison of silane deposition methods. (a) Solution-
phase deposition of APTES.  Trace levels of water in the reaction 
solution result in (i) the deposition of nonuniform monolayers, (ii) 
codeposition of aggregated silanes, and (iii) the hydrolytic 
stripping of predeposited silanes.  (b) Chemical-vapor deposition 
(CVD) of APTES produces relatively uniform and defect-free 
monolayers.  Only monomeric silanes are deposited, as large 










Figure 1.5: Silane chemistry: (a) The reaction of a N-hydroxysuccinimidyl (NHS) 
ester to an APTES modified surface forming a covalent amide bond.  The blue 
circle represents any molecule capable of being modified with NHS functionality.  
(b) The reaction of GOPTS by nucleophilic substitution of any molecule (blue 
circle) containing hydroxyl-, amine-, or thiol-functionality to form a covalent 




conjugation sites because the density of receptor sites on an interface directly affects the 
signal response, sensitivity, kinetics, and capture activity of the resulting 
measurements.
12,20,93,94
 By adjusting the ratio of biotin-PEG to the diluent mPEG, the 
density of biotin receptor sites can easily be controlled,
91,92
  
Although the activities of immunoassays have been extensively studied using 











 little has been reported at the single-molecule level.  By controlling the 
densities of immobilized receptor sites down to very small fractions of a monolayer, 
TIRF imaging can be employed to study the activities and heterogeneity of ligand-
receptor interactions occurring at a glass-water interface at a single-molecule level.  By 
studying such interactions at low receptor surface concentrations, the capture activities of 
individual receptor molecules can be characterized in the absence of transport limitations 
that govern the kinetic response of high density capture surfaces and bivalent interactions 
resulting from closely packed capture sites.  Understanding these fundamental interfacial 
ligand-receptor interactions will aid in preparing SPIs with higher sensitivity, lower limits 
of detection, and that exhibit kinetics that more accurately represent the biorecognition 
processes.  
 
1.6 Protein Immobilization through Streptavidin Tethering 
The strept(avidin)-biotin interaction has commonly been applied to SPIs as a 
means to mediate the immobilization of capture proteins to a measurement surface.  
Strept(avidin) is an extremely stable homotetramer molecule that binds the small 








simultaneously binding multiple biotins at once, the protein avidin binding complex 
(PABC) has previously been used as a bridge to immobilized biotin-functionalized 
antibodies to biotinylated-surfaces, as illustrated in Figure 1.6.
98
 In some cases, capture 
antibodies immobilized through the strept(avidin) bridge exhibited up to 400 times more 
activity compared to antibodies passively adsorbed to a solid surface.
99
 The 
strept(avidin)-biotin interaction not only helps maintain the activity of surface-
immobilized capture proteins, but it also provides a nearly universal means to irreversibly 
immobilize any biotin-conjugated capture protein onto the aforementioned biotinylated-
PEG modified surfaces at a controlled density.
91,100,101
 Although the PABC 
immobilization strategy has many advantages, surface-immobilized strept(avidin) 
molecules exhibit poor capture yields.
8
 The poor capture activity exhibited by surface 
immobilized strept(avidin) has been reported as a qualitative observation;
8
 however, little 
quantitative information has been documented on the activity, behavior, and 
heterogeneity of surface-immobilized streptavidin. 
 
1.7 Total Internal Reflection Fluorescence Microscopy 
There are numerous measurement challenges that must be overcome in order to 
monitor discrete molecular interactions at a glass/water interface using optical based 
techniques.  The instrumentation must be sensitive to submonolayer coverages, while 
having a high spatial resolution capable of resolving individual molecules.  Total Internal 
reflection fluorescence (TIRF) has the ability to simultaneously fulfill these requirements 
by selectively illuminating and exciting fluorophores contained within a small distance 


































































































































































































center into the back of a high numerical aperture (NA) objective and projected onto a 
glass/water interface at an angle of incidence greater than the critical angle (θc).   Total 
internal reflection (TIR) occurs when light hits an interfacial boundary traveling from a 
higher refractive index (n1) medium to a lower refractive index (n2) medium at an angle 





                                                      (1.5) 
 
Upon TIR, an evanescent field (nonpropagating electromagnetic wave) is produced that 
decays exponentially in intensity (I(z)) with distance (z) normal from the interface, as 
defined by equation 1.6, where I0 is the intensity at the interface (z=0) and dp the 
penetration depth of the evanescent field into the lower refractive index medium. 
 
𝐼(𝑧) =  𝐼0𝑒
−𝑧 𝑑𝑝⁄                                                    (1.6) 
 
The dp, as defined by equation 1.7, is a function of the incident wavelength (λi), angle of 





𝑑𝑝 = 𝜆𝑖 2𝜋⁄ 𝑛1√sin2 𝜃𝑖−(𝑛2 𝑛1)⁄
2                                          (1.7) 
 
As illustrated in Figure 1.7, our experimental setup utilized a 532 nm laser beam 






















Figure 1.7: A 532 nm laser is coupled into a single mode fiber and focused 
into the back of a 1.45 NA objective.  TIR, achieved by translating the 
incoming light off center to the objective, produces an evanescent wave, 
exciting only fluorophores contained within the first 150 nm of the surface.  
Fluorescence from the excited molecules is then collected back through the 
same objective, passed through a 552 nm dichroic beamsplitter and 585/40 nm 






























sample interface at an angle θi ≈65-75°.  The refractive indices, n1 =1.47 (borosilicate 
glass) and n2 =1.33 (water) generated TIR, which produces an evanescent wave  
penetration depth of ~150 nm.  The emission from the excited fluorophores residing 
within the first ~150 nm from the glass surface is then collected back through the same 
objective and imaged onto a high efficiency charge coupled device (CCD) camera.   
Because only molecules within the first ~170 nm of the surface are excited, background 
signal from molecules in the bulk solution are minimized allowing TIRF imaging at high 
signal-to-noise and diffraction-limited spatial resolutions. 
 
1.8 Single Molecule Imaging 
Single molecule total internal reflection fluorescent (SM-TIRF) imaging has 
many advantages for interrogating the activity of proteins at interfaces.  As previously 
discussed, it is well known that proteins immobilized to solid surfaces behave quite 
differently compared to that in free solution, and a large fraction of receptor proteins are 
inactivated when immobilized to a solid surface.  Characterizing such processes using 











 cannot report heterogeneity at individual receptor-ligand 
levels.  Using single-molecule TIRF, it is possible to resolve individual receptor-ligand 
interactions and colocalize every subsequent capture event, or lack thereof, versus time.    
In addition, utilizing a low density of capture sites avoids transport limitations, bivalent 
interactions, and recapture processes.  
Although SM-TIRF imaging has many advantages, this fluorescence-based 




are susceptible to photobleaching.  By employing intermittent imaging, exposing the 
sample briefly to light and imaging at regular intervals in time, any protein-conjugated 
dye molecules are exposed to a minimal amount of excitation.  When the intermittency 
factor is optimized, nearly all photobleaching can be eliminated.  Using intermittent TIRF 
imaging, the ligand-receptor interactions can be monitored over many hours with 
negligible false negative observations arising from photobleaching of the fluorescent 
labels.  
 
1.9 Overview of the Dissertation 
 The goal of this research is to develop single molecule TIRF techniques capable 
of characterizing biologically relevant ligand-receptor interactions at a solid-liquid 
interface.  As previously discussed in this chapter, there are many challenges to overcome 
in order to observe and measure individual ligand-receptor interactions at glass-water 
interfaces.  Because of the extreme sensitivity of single-molecule TIRF microscopy, the 
measurement surfaces must be resistant to the nonspecific adsorption of proteins, while 
maintaining the ability to control the site density of immobilized receptors.   
 In order to selectively monitor individual interfacial ligand-receptor interactions 
at the single-molecule level, the capture surface must first be highly resistant to 
nonspecific protein adsorption. As presented in Chapter 2, poly(ethylene glycol) (PEG) is 
grafted to glass slides in order to prepare a surface with resistance to the nonspecific 
adsorption of proteins.  The goal of this research is not only to prepare a surface that has 
low biofouling properties, but also to investigate how the chemistry used to immobilize 




PEG-modified glass slide.  Two small functional alkyl-silanes, (3-
aminopropyl)triethoxysilane (APTES) and (3-Glycidyloxypropyl)trimethoxysilane 
(GOPTS), are deposited onto glass cover slides using CVD as a means to subsequently 
graft functional-PEG molecules.  The amine-functionality of the APTES-derivatized 
slides is suitable for further modification using well-developed N-hydroxysuccinimide 
(NHS) ester chemistry.  A monolayer of 2000 g/mol PEG-NHS is covalently grafted to 
APTES modified slides.  In contrast, the epoxide-functionality of the GOPTS-derivatized 
slides readily undergoes substitutions with a variety of nucleophiles.  Both 750 g/mol and 
2000 g/mol PEG-amine are covalently grafted to the GOPTS-modified surfaces.  The 
resistance to nonspecific adsorption of proteins is characterized using a monoclonal, 
mouse-derived cy3-labeled antibiotin (MsIgG) molecule.  The higher resistance to 
protein adsorption exhibited by slides prepared by reaction of 2000 g/mol PEG-amine to 
an epoxide-modified surface suggests that the higher stability of epoxide functionality 
produced a more uniform surface with fewer defects.  In addition, the results also indicate 
that, for similar grafting chemistries, the high conformational entropy associated with the 
larger PEG chain better resists the adsorption of antibodies.      
 Controlling the surface concentration of receptor molecules is not only critical in 
resolving single-molecule binding events, but it is also important in overcoming transport 
limitations and crowding effects that can influence interfacial ligand-receptor kinetics.  In 
Chapter 3, the epoxide-based chemistry developed in Chapter 2 is adapted to control the 
surface concentration of biotin conjugation sites in an mPEG-diluent monolayer on glass 
slides.  By diluting in a small concentration of 2300 g/mol biotin-PEG-amine into a 




conjugation sites can be controlled.  The extremely high affinity of biotin for 
strept(avidin) makes biotin an ideal choice for subsequent conjugation steps.  
Streptavidin, a tetravalent molecule, can simultaneously bind multiple biotin molecules, 
and has been extensively used as an intermediate tether to immobilize biotin conjugated 
biomolecules to surfaces.
21,91,92,103-105
 The density of biotin conjugation-sites associated 
with the modified PEG surfaces are characterized using fluorescently-labeled streptavidin 
molecules.  Increasing the concentration of biotin-PEG-amine in the reaction solution, 
containing a fixed concentration of mPEG-amine, results in a linear increase in the 
observed conjugation site density.  The resulting surfaces produced conjugation site 
densities down to very low fractions (10
-6
) of a streptavidin monolayer.  
 The modified surface prepared in Chapter 3 allows ligand-receptor interactions 
commonly utilized in solid-phase immunoassays (SPIs) to be investigated at a single-
molecule level using TIRF imaging.  In many cases the activity of surface immobilized 
capture antibodies differ greatly from free solution measurements. It is thought that the 
orientation of a protein receptor with respect to the surface affects the activity of the 
immobilized capture molecule.  In Chapter 4, the activity of fluorescently-labeled rabbit 
derived antigoat IgG (anti-GtIgG) capture antibodies is tested using four different 
immobilization strategies: (i) passive adsorption to an mPEG surface, (ii) active, but 
random biotin-immobilization directly to streptavidin capture sites, (iii) an oriented two-
step immobilization sequentially through streptavidin and E. coli protein A (EpA) 
intermediate, and (iv) an oriented one-step immobilization to streptavidin as a chimeric 
[EpA/anti-GtIgG] complex.  The activity of each capture antibody immobilization 




(GtIgG).  The use of fluorescent labels in each step allows all subsequently bound 
proteins to be colocalized to previously known capture locations.  As a result, the 
activities of individual capture proteins and protein-protein complexes are directly 
observed at a site-to-site basis.  From these results, it becomes clear how the orientation 
of capture sites and the means of protein-receptor immobilization affects the activity of 
individual capture sites and how that correlates to the activity of the surface as a whole.   
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IMMOBILIZATION OF POLY(ETHYLENE GLYCOL) ON GLASS 
TO PREPARE PROTEIN-REPELLENT SURFACES 
 
2.1 Introduction 
Poly(ethylene glycol)  (PEG) is a synthetic nontoxic water soluble polymer that 
exhibits excellent resistance to protein adsorption when immobilized at a solid/liquid 
interface.
1-4
 The antifouling properties associated with PEG have made these coatings 
widely used for a variety of bioanalytical sensor surfaces.
5-7
 Interfacial-based assays 
typically utilize heterogeneous platforms where one of the interacting biomolecules is 
immobilized to the sensor surface.  The binding of a solution-phase biomolecule to a 
selective capture site results in a measured signal using a variety of optically based 
techniques, some of which include surface plasmon resonance (SPR), fiber-optic 
fluorescence, and total internal reflection fluorescence (TIRF).
8,9
 The sensitivity and 
selectivity of such measurements highly depend on the ability of the sensor surface to 
resist the nonspecific adsorption of biomolecules.
10
 As a result, many sensors have 
utilized PEG functionalization as the basis for low fouling interfacial supports.  The 
ability PEG has to resist the adsorption of biomolecules has been attributed to steric 
interactions between densely packed PEG polymer chains,
11
 high conformational 
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mobility that defines large exclusion volumes,
12-14
 and a large free energy barrier to 
displacing tightly associated water molecules.
13,15-17
 Both the molecular weight and the 
density of the grafted PEG layer directly influence the nonspecific adsorption properties 
exhibited by a functionalized surface.
18,19
 In addition, the protein-resistant properties 
exhibited by these surfaces vary greatly depending on the chemistry used to graft 
monolayers of PEG.  By better understanding how the immobilization chemistry used to 
deposit PEG molecules onto a surface affects the resulting protein resistance properties, 
sensor platforms with optimal protein-resistant properties can be reproducibly 
manufactured.  
The excellent biocompatibility properties exhibited by poly(ethylene glycol) 
(PEG) in conjunction with the wide variety of commercially available functional 
conjugates has stimulated much research into developing methods for the immobilization 
of PEG chains to surfaces, as a means to reduce the nonspecific adsorption of 
biomolecules.  For passivation of glass substrates, PEG has been deposited through three 
primary strategies: passive physisorption, electrostatic interactions, and covalent 
attachment.  The simplest, yet least stable method for producing protein resistance 
coatings, has utilized nonspecific adsorption of PEG polymers onto glass surfaces.
20,21
 In 
such cases, the physisorbed PEG polymers, weakly bound through Van der Walls 
interactions, readily desorb from the interface when exposed to aqueous solutions, 
resulting in surfaces that increasingly foul over time.
22,23
 As a means to increase the 
attachment strength and stability of the PEG layer, poly-(L-lysine) modified with PEG 
(PLL-g-PEG) has been electrostatically deposited onto negatively charged oxide surfaces.  
Being cationic at neutral pH, the poly-(L-lysine) backbone readily adsorbs to anionic 
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glass or other oxide surfaces.  These electrostatic interactions strongly anchor the PLL-g-
PEG copolymers to the anionic oxide interfaces.
24
 Although, this method has successfully 
shown to greatly reduce the nonspecific adsorption of proteins in comparison to untreated 
oxide surfaces, the electrostatic interactions holding the PLL-g-PEG layer to the surface 
can easily be disrupted by high ionic strength or high and low pH solutions.  Exposure to 
such conditions can cause the PLL-g-PEG layer to desorb from the oxide surface, leaving 
the surface vulnerable to protein adsorption.
24-27
   
In contrast to physisorption techniques, covalent immobilization of PEG has been 
shown to provide the most stable means of producing surfaces resistant to the adsorption 
of proteins. Organo-silanes, which are highly reactive with glass surfaces, have 
commonly been used to covalently immobilized functionalized-PEG molecules to glass-
type surfaces through both direct and indirect methods. PEG monolayers have been 
directly immobilized to glass surfaces through the self-assembly of alkoxysilylated-PEG 
molecules.
28
 The resulting PEG monolayers were capable of reducing the adsorption of 
fibrinogen by nearly 20 times compared to that of unmodified glass-type surfaces.
29
 
Although, these functionalized surfaces are highly stable and resistant to the adsorption 
of fibrinogen, the commercial sources of alkoxysilylated-PEG are very limited, and its 
synthesis is time consuming and difficult.  With a wide variety of other functionalized-
PEG molecules and alkyl-silanes commercially available, there have been many simple, 
yet indirect alternatives developted to covalently immobilize PEG monolayers onto glass 
surfaces using an intermediate layer of a functionalized-silane.
30-32
  
The degree to which PEG functionalized surfaces are able to resist the nonspecific 
adsorption of proteins is greatly dependent on the density and homogeneity of the 
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deposited monolayer.  When considering the indirect two-step deposition of 
monofunctional PEG molecules onto a glass surface, the density of the final grafted PEG 
monolayer can never be greater than that of the reactive alkyl-silane monolayer.  It is 
vital that the reactive silane foundation exist as a uniform, defect-free monolayer in order 
to maximize the density and homogeneity of the subsequently deposited functionalized 
layers.  Much work has been conducted to establish reproducible and simple methods to 
obtain uniform organo-functionalized silane monolayers on glass or other oxide 
surfaces.
33-35
 Previously, glass supports have been modified with organo-functionalized 
silane monolayers using both solution-phase and gas-phase deposition methods;
34,36-40
 
however, the formation of uniform functionalized monolayers has proven to be quite 
challenging.
41,42
 Trifunctional alkoxy- or chloro-silanes are advantangous for producing 
stable monolayers through cross-linking. These trifunctional silanes are susceptible 
oligomerization in the presence of water, so that solution-phase deposition methods 
require the use of extremely dry solvents in order to prevent the formation of silane 
aggregates in solution resulting in defects within the deposited monolayer.
34,43-45
 These 
defects can be the result the accumulation of oligomers, or nonuniform multilayers, co-
deposition of aggregated silanes, and hydrolytic stripping of predeposited silanes.
37,44,46,47
 
Such imperfections present within the functionalized foundation layers can often be 
propagated through succeeding reaction steps, which result in defect adsorption sites for 
biomolecules.  In contrast, the chemical vapor deposition (CVD) of organo-
functionalized silanes has been shown to overcome some of these limitations and 
reproducibly deposit uniform functional monolayers on silicon dioxide surfaces.
37
 
Wikstroem et al. reported the deposition of uniform and relatively defect free monolayers 
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of (3-Glycidyloxypropyl)trimethoxysilane (GOPTS) and (3-aminopropyl)triethoxysilane 
(APTES) onto porous silica surfaces using CVD methods.
33
  
With the wide variety of functionalized PEG conjugates commercially available, 
both APTES and GOPTS have provided simple and cost effective means of covalently 
grafting PEG to glass surfaces.  N-hydroxysuccinimide (NHS) active esters of PEG are 
reactive with primary amines at pH ranging from 7 to 9 and have previously been used to 
immobilize NHS conjugated molecules to APTES-modified surfaces through the 
formation of a stable amide bond. A major disadvantage to using NHS ester chemistry is 
that under high pHconditions, the reactive NHS esters readily hydrolyze to nonreactive 
carboxylic acids.
48
  Yasuhiro et al. reported that for a 20 kDa NHS-PEG, the active-ester 
has a half-life of approximately 2 hours at pH 7.4, yet approximately 10 minutes at pH 
9.
49
 Given the pKa for an APTES monolayer on glass is approximately 9,
50
 balancing the 
reaction pH to promote the formation of amide bonds with the neutral amine while 
limiting the hydrolysis of the active ester can be a challenge to overcome.   
In contrast to NHS ester chemistry, the epoxide surface functionality resulting 
from the deposition of GOPTS onto glass can be reacted with a variety of nucleophiles to 
form covalent linkages.
32
 Specifically at pH 10.1, the epoxide-group is highly reactive 
toward amine-conjugates.
51
 Unlike the NHS ester functionality, the epoxide groups are 
stable at near neutral pH and above; therefore, reaction of amine with epoxide surface 
groups is not in competition with side reactions such as hydrolysis.  As a result, this 
reaction requires less starting material and maintains activity over longer periods of time.  
Any reduction in reaction rates at lower amine conjugate concentrations can be 
compensated with longer incubation times. 
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In many cases, the covalent immobilization of PEG molecules at glass interfaces 
results in insufficient packing densities to optimally prevent the adsorption of 
proteins.
52,53
 The low PEG densities in such cases have been attributed to the deactivation 
of terminal reactive groups through competing side reactions such as the hydrolysis of 
NHS ester functionality.  Also, the steric constraints involved in densely packing large 
PEG polymers onto a surface can greatly slow reaction rates at high surface coverages.
30
    
It has been shown that the ability of PEG to resist the adsorption of proteins onto surfaces 
increases as a function of molecular weight up to 2000 g/mol;
54
 however, the repulsive 
forces resulting from densely packing larger polymers onto a surface also increases 
proportionally with molecular weight.  When higher molecular weight polymers are 
immobilized at a surface through small terminal reactive groups, there is a critical surface 
density where the rate of covalent bond formation decreases exponentially with surface 
coverage as a result of steric repulsive forces.
55
 These decreased reaction rates in 
conjunction with competing side reactions can easily limit the final surface concentration 
of the grafted PEG layer.  It becomes clear how the coupling chemistry used to covalently 
graft PEG and the size of the polymers being immobilized can greatly influence the 
resulting protein adsorption properties of the surface.  
In this work, the protein adsorption properties of glass surfaces passivated by two 
common PEG immobilization strategies were characterized and compared using single 
molecule total internal reflection fluorescence (TIRF) imaging. As illustrated in Figure 
2.1, glass surfaces were activated with either APTES or GOPTS monolayers using CVD 
in order to produce a uniform functionalized monolayer to which monofunctional PEG 































































































































































































the amine functionality resulting from glass slides modified with APTES, and for the 
glass slides modified with GOPTS, mPEG-amine was grafted to the surface epoxide 
functionality. In addition, two different molecular weight (750 g/mol and 2000 g/mol) 
mPEG-amine molecules were immobilized to GOPTS-modified surfaces and then 
compared.  The adsorption of monoclonal cy3-labeled, mouse derived IgG (MsIgG) to 
each of the three surfaces was monitored using TIRF imaging.  All three methods 
resulted in excellent resistance to the adsorption of cy3-MsIgG down to small (10
-6
) 
fractions of a monolayer; however, significant differences in the adsorption of cy3-
MsIgG were observed between each of the grafting methods at the single-molecule 
resolution limit.  From these results, the influence in which the immobilization chemistry 
and molecular weight of immobilized PEG has on the protein adsorption properties of the 
surface was revealed.  
 
2.2 Experimental 
2.2.1 Reagents and Materials 
(3-Glycidyloxypropyl)trimethoxysilane (GOPTS), (3-Aminopropyl)triethoxy-
silane (APTES), methoxypoly(ethylene) glycol amine (mPEG16-amine) with an average 
molecular weight (Mn) of 750 g/mol were purchased from Sigma Aldrich (St. Louis, 
MO). Methoxypoly(ethylene glycol) amine (mPEG43-amine) with Mn=2000 g/mol and 
methoxypoly(ethylene glycol) succinimidyl carboxymethylester (mPEG43-NHS) with 
Mn=2000 g/mol was obtained from JenKem Technology USA (Tianjin, China).  
Monoclonal mouse derived cy3-labeled antibiotin (MsIgG) was purchased from Jackson 
Immunoresearch Laboratories Inc (West Grove, PA).  All chemicals were used as 
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received.  The degree of cy3- labeling was characterized using a Thermo Scientific 
(Wilmington, DE) NanoDrop 2000 UV-vis spectrometer at wavelengths 280 and 550nm.  
Gold Seal microcover glasses (22 X 22mm No. 1.5) were purchased from VWR (West 
Chester, PA). 
 
2.2.2 Surface Derivatization 
The immobilization of PEG monolayers onto glass substrates began with the 
cleaning of 10 vertically racked glass cover slides by immersion in a freshly prepared 
mixture of H2SO4 and 30% H2O2 (2:1 vol).  After a 20-minute incubation period, the 
slides were rinsed 6 times with 18MΩ-cm H2O.  This was immediately followed by 
treatment in a 75C base bath composed of H20, NH4OH, and 30% H2O2 (5:1:1 vol) for 
10 minutes.  Slides were rinsed 3 times with 18MΩ-cm H2O and dried under a stream of 
ultra-high purity nitrogen. 
The deposition of APTES and GOPTS was achieved out of the vapor phase.  In 
each case, the slide holder, containing 10 vertically racked clean glass cover slides, was 
placed in a glass vessel containing 500 L of the respective alkyl-silane (APTES or 
GOPTS). The slide holder was an adequate height to suspend the cover slides above the 
bottom of the container in order to avoid direct contact with the reactive liquid alkyl-
silane.  The reaction vessel was then sealed and incubated, for 18 hours, in a convection 
oven previously heated to 60C.  After the reaction period, the rack of slides was 
removed from the container and further incubated in an empty oven for an additional 5 
minutes at 60C.  The slides were removed from the oven and allowed to cool to room 
temperature before further derivatization. 
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The grafting of monofunctional PEG molecules, previously described in Figure 
2.2, onto both APTES- and GOPTS-activated surfaces was started by separately placing 
each functionalized slide horizontally in the bottom of a 30 ml beaker.  In the case of 
amine functionalized slides activated with APTES, a freshly prepared solution, 
containing 5 M of 2000 g/mol mPEG-NHS in 100 mM pH 8.3 carbonate buffer, was 
then added in sufficient volume (~2 ml) to cover each individual slide.  The beakers were 
then covered, placed on a titer plate shaker, and allowed to react under slow orbital shear 
for 4 hours at room temperature.  After the reaction period was complete, the slides were 
then rinsed 3 times in 20-mM phosphate buffered saline (PBS) at pH 7.5, 100 mM ionic 
strength.  The slides were stored in 20-mM PBS for no longer than 1 week prior to their 
characterization. 
The 10 epoxide-functionalized slides activated with GOPTS were split into two 
groups where 5 slides were then reacted with mPEG-amine of either mean Mn of 750 
g/mol or 2000 g/mol.  The low molecular weight PEG was grafted to the GOPTS 
modified surface by freshly preparing a solution containing 1 mM 750 g/mol mPEG-
amine in 100 mM pH 10.1 carbonate buffer.  Approximately 4 ml of the 750 g/mol 
mPEG-amine solution was then added to each slide-containing beaker, from the first 
group of 5 slides, such that each slide was fully submerged in reaction solution.  
Similarly, the high molecular weight PEG was grafted from a solution containing 1 mM 
2000 g/mol mPEG-amine in 100 mM pH 10.1 carbonate buffer.  Sufficient volume (~4 
ml) of the 2000 g/mol mPEG-amine solution was added to cover each slide.  In both 
cases, the slide-containing beakers were then covered and placed on a titer plate shaker.  
The slides were allowed to react for 18 hours under slow orbital shear at room 
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temperature.  After the reaction period was complete the mPEG functionalized slides 
were rinsed 3 times in 20-mM PBS, and then stored in PBS for no longer than 1 week 
prior to their characterization. 
 
2.2.3 Characterization of Protein Adsorption 
The degree of protein adsorption each surface exhibited was characterized by 
monitoring the accumulation of cy3-labeled monoclonal mouse-derived antibiotin 
(MsIgG) using single molecule total internal fluorescence (TIRF) imaging.  Each 
respective slide was first assembled into a 4-L flow cell, loaded onto the microscope, 
and rinsed under the continuous flow of 20 mM PBS with 0.1% Tween 20.  The flow rate 
for all MsIgG incubation and rinse periods was 30 ml/h.  While rinsing, the slides were 
photobleached for 15 minutes using a 532 nm laser operating at 12 mW of power in order 
to remove any inherent background fluorescence.  Afterwards, 1 nM (150 ng / ml) cy3-
MsIgG in of 20 mM PBS with 0.1% Tween 20 was continuously flowed through the 
sample cell.  The accumulation cycle for each sample was allowed to reach saturation (50 
to 100 minutes) where the protein surface density did not increase with time.  After the 
accumulation cylce was complete, the sample was then rinsed with 20 mM PBS with 
0.1% Tween 20 under continuous flow.  Again, the protein surface density was allowed 
to reach steady state before stopping the rinse cycle (typically ~100 minutes).  
 
2.2.4 Single Molecule Imaging 
The single molecule imaging of the cy3-MsIgG was achieved using an Olympus 
inverted microscope.  The frame was modified with an in-house built microscope stage 
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using a piezoelectric NanoFlex translation stage (ThorLabs), capable of maintaining 
focus over long observation times (> 5 hours).  The cy3-antibody was illuminated using 1 
mW, into the objective, of 532 nm laser (B&W TEK inc.) light.  The laser beam was 
focused into a single mode fiber and refocused into the back of an Olympus plan apo 
60X, 1.45 NA, oil immersion objective.  The incoming laser light was translated off 
center until total internal reflection excitation was achieved.  Emitted fluorescence was 
collected back through the same objective, passed through a 552 nm BrightLine dichroic 
beamsplitter (Semrock) and 585/40 nm BrightLine bandpass filter (Semrock), and 
imaged using an Andor iXon+ CCD camera. In order to ensure photobleaching did not 
occur over the course of the entire experiment, intermittent imaging was used.  Images 
were obtained every 2 minutes at 150 mseconds integration exposures.  
 The resulting images were then imported into ImageJ to be analyzed.
56
 The 
average pixel-to-pixel intensity and standard deviation were determined for three 
modified glass slides after photobleaching, yet prior to the injection of cy-MsIgG.  For 
slides containing adsorbed cy-MsIgG, the identification of single-molecules was set such 
that a fluorescent spot must have an area >4 pixels
2
 and an average intensity greater than 
a set threshold above background, as discussed below.  All identified single molecules 
were located and counted for each of the prepared surfaces 
 
2.3 Results 
2.3.1 Surface Preparation 
 The ability of a PEG modified surface to resist the nonspecific adsorption of 
proteins depends critically on the density and uniformity of the grafted monolayer.  When 
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immobilizing functionalized-PEG molecules to glass surfaces through reactive alkyl-
silane intermediates, one of the most crucial steps to achieving optimal resistance to 
protein adsorption is the deposition of a uniform and defect-free functionalized silane 
foundation layer.  In these experiments, silane monolayers were achieved by depositing 
APTES and GOPTS onto clean glass cover slides by CVD.  Heating the reaction vessel to 
60C for 18 hours promotes an increase in alkyl-silane vapor pressure and crosslinking of 
the deposited silane monolayer to the glass surface.  After the reaction period, the slides 
were further incubated in an empty oven at 60C for 5 minutes in order to desorb any 
excess physisorbed silane from the surface, leaving a uniform amine or epoxide-
functionalized monolayer.  The unmodified glass slides were totally hydrophilic after the 
cleaning process, reflected by a nonmeasurable water contact angle.  After the deposition 
of APTES and GOPTS, the hydrophobicity of each alkyl-silane modified surfaces 
increased.  A water contact angle of Θ=15 ± 3º was observed for the APTES modified 
surfaces, compared to Θ=45 ± 4º for the surfaces modified with GOPTS. 
 The covalent immobilization of mPEG to glass slides was accomplished using 
two methods: (i) the reaction of N-hydroxysuccinimide (NHS) active esters of mPEG to 
the amine functionality of APTES modified glass slides, and (ii) the reaction of 
monofunctional mPEG-amine reacted to the epoxide functionality of GOPTS derivatized 
glass slides, both reactions are illustrated in Figure 2.2.  The immobilization of mPEG-
NHS to APTES derivatized glass slides was achieved by incubating the modified slides 
in an aqueous solution containing 100 mM mPEG-NHS at pH 8.3 for 4 hours.  A major 
disadvantage of N-hydroxysuccinimide ester chemistry is that the active esters are highly 
susceptible to hydrolysis in the presence of even trace levels of water.
48
  In competition 
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with the reaction of mPEG-NHS to surface amines, the hydrolysis of NHS decreases the 
concentration of reactive PEG in solution over time.  Furthermore, the rate of hydrolysis 
for the mPEG-NHS is highly dependent on pH and increases rapidly with increasing pH.  
At pH 7, a 2000 g/mol mPEG-NHS has been reported to have a half-life of approximately 
120 minutes, whereas at pH 9, the half-life is only 9 minutes.
49
 By immobilizing the 
NHS-PEG to APTES modified slides from a solution of pH 8.3, the rate of hydrolysis of 
the NHS ester was slowed.
48
 Because the pKa of the APTES modified surface (~9) was 
above the pH of reaction solution, the rate of aminolysis was also slowed.  In an attempt 
to increase the formation of the amide bond to the amines on the surface, a large excess 
(100 mM) of NHS-PEG was used.  After the 4-hour reaction was complete, the slides 
were rinsed 3 times with PBS in order to remove any physisorbed PEG molecules.   
The second immobilization strategy utilized the reaction of mPEG-amine to the 
surface epoxide groups on the glass slides previously modified with GOPTS. Epoxide 
groups are very reactive with amine-functionalized molecules at pH 10.1, forming a 
covalent bond as shown in Figure 2.2.  Unlike the NHS ester functionality, the epoxide 
groups are stable at high pH and are not in competition with side reactions such as 
hydrolysis.   Thus, the reaction of mPEG-amine to the surface epoxide groups could be 
carried out over longer times and at a much lower (100-fold) concentration of the 
reactive-PEG compared to the N-hydroxysuccinimide ester method.  The longer reaction 
times could help overcome the slowing of reaction rates at high coverages that arise from 
steric repulsion.
55
  As the population of covalently immobilized PEG on the surface 
grows, it becomes increasingly more difficult for a large polymer to insert in a specific 
orientation in which the terminal amine can react with an epoxide group.  By allowing the 
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GOPTS slides to incubate in the mPEG-amine solution for 18 hours, the slower reaction 
rates resulting from repulsive interactions between tightly packed polymer chains might 
be overcome.  Both 750 g/mol and 2000 g/mol mPEG-amine were grafted to GOPTS 
modified glass slides in order to investigate how the molecular weight of the grafted PEG 
affects the protein resistant properties exhibited by each modified surface.   
 
2.3.2 Single Molecule Imaging 
The resistance to nonspecific adsorption of proteins was evaluated for each of the 
three methods used to prepare glass slides covalently modified with monofunctionalized 
PEG molecules by using single-molecule total internal reflection fluorescence (TIRF) 
imaging.  By evaluating the ability of a surface to resist protein adsorption at the single-
molecule level, information about the surface defects on the scale of individual molecules 
level could be revealed.  Each PEGylated slide was assembled into a flow cell, loading 
onto an inverted TIRF microscope, and illuminated with a 532 nm laser.  The modified-
glass slides were photobleached, under continuous flow of 20-mM PBS, for 15 minutes 
in order to remove any background fluorescence from surface impurities.   After 
photobleaching the glass surface, 1 nM (150 ng/ml) of cy3-labeled mouse derived 
monoclonal IgG antibiotin (cy3-MsIgG) was injected at a flow rate of 30 ml/hr.  
Considering the flow cell, illustrated in Figure 2.3, used in all experiments was 4 l in 
volume, the sample cell volume was replenished in its entirety approximately once every 
500 ms with fresh cy3-MsIgG solution.  As a result, transport limitations of cy3-MsIgG 
to the surface and loss of cy3-MsIgG from solution due to the adsorption of protein to the 




Figure 2.3: A ~4 µl flow cell.  Dimensions: 1 cm × 0.26 




MsIgG, accumulation of cy3-MsIgG was monitored until the population of surface 
associated antibodies remained constant, at which point the sample was washed with PBS 
with 0.1% Tween 20 until all weakly associated cy3-MsIgG was removed and the 
population of irreversibly adsorbed cy3-MsIgG remained constant.  Images were 
collected intermittently, once every 2 minutes with a 150 ms exposure time, in order to 
prevent the photobleaching of strongly adsorbed molecules that persist over the duration 
of each experiment. If a cy3-MsIgG is adsorbed for the entire 180-minute experiment, the 
intermittent imaging would result in 13.5 seconds of exposure to 1 mW laser radiation.  
In a control experiment where immobilized cy3-MsIgG molecules were continuously 
exposed to 1 mW of laser radiation while images were collected in real-time at 150 ms 
integration periods, the rate of photobleaching of the cy3-mAb under continuous 
illumination had a time constant of τPB ≈ 190 seconds, as shown in Figure 2.4.  
Considering the molecules accumulate slowly over the 180-minute experiment, the 
typical molecule experiences much less than 13.5 seconds of illumination and the 
probability of a false-negative occurring from the result of photobleaching is small 
(<0.07). 
The threshold for counting of single molecule cy3-MsIgG, plotted in Figure 2.5, 
was established by measuring the average background intensity of the photobleached 
slides prior to introduction to cy3-MsIgG.  The average background fluorescence level of 
the photobleached slides was B = 9.8 photoelectrons, while a variation in pixel-to-pixel 
background counts had a standard deviation of σB = 2.5 photoelectrons. The threshold for 
counting single cy3-MsIgG molecules, Lc, was set such that a spot >4 pixels
2
 in area have 




Figure 2.4: Histogram of survival times for the photobleaching of 
cy3-MsIgG with an average of 4.5 ± 1.2 dyes/protein at 1 mW of 532 
nm laser light fit to a single exponential decay: N = No exp(t/τPB), 






Figure 2.5: Histogram of background intensity fit to an exponentially 
modified Gaussian distribution (red) and the intensity of individual cy3-
MsIgG adsorbed to a PEG modified surface fit to an exponentially 
modified Gaussian distribution (black).  The dashed line sets the 




probability of false positives arising from fluctuations in the background was negligible 
(>10
-10
).  The average fluorescence intensity, Ab, collected from individual adsorbed 
cy3-MsIgG was 62 photoelectrons, with a standard deviation in spot-to-spot peak 
intensities of σMsIgG = 11 photoelectrons.  The large variation in cy3-mAb intensity likely 
arises from variations in the number of labels covalently carried by each MsIgG 
molecule.  Based on the relative absorbance at 280 nm and 550 nm,
57
 MsIgG was labeled 
with 4.5 ± 1.2 cy3 molecules. 
 
2.3.3 Protein Adsorption 
 Cy3-labeled mouse derived monoclonal IgG antibiotin (cy3-MsIgG) was used to 
assess the amount of protein adsorption exhibited by each of the three methods for 
PEGylating glass slides. Shown by the time-dependent accumulation experiments in 
Figure 2.6, the quantity of nonspecific adsorption, resulting from a 1 nM (150 ng/ml) 
solution of cy3-MsIgG, exhibited by each of the three PEG derivatized glass slides was 




 fraction of a 
150 kDa IgG monolayer, an estimate which ranges from ~ 0.2 to 0.5 μg/cm2 (1.3 to 
3.3pmol/cm
2
) depending on IgG orientation.
58,59
 Because of the sensitive nature of the 
single molecule fluorescence imaging used in this experiment, the nonspecific adsorption 
of cy3-MsIgG to untreated glass surfaces was much greater than the upper limit for 
resolving discrete molecules, which was approximately 32 pg/cm
2





 fraction of an IgG monolayer.  The degree of fouling is illustrated in Figure 2.7, 
with images of adsorbed antibody to each of the three PEG modified surfaces and an 





Figure 2.6: Accumulation  and desorption of 1 nM cy3-
MsIgG  to each PEG modified surface: (black) 2000 
g/mol NHS-PEG reacted to APTES derivatized glass 
surface, (red) 750 g/mol amine-PEG reacted to GOPTS 
modified glass surface, and (blue) 2000 g/mol amine-PEG 





Figure 2.7: Images of individual cy3-MsIgG molecules remaining 
strongly adsorbed after the accumulation and wash cycle: (a) Bare 
glass, (b) 2000 g/mol amine-PEG reacted to APTES modified glass, 
(c) 2000 g/mol amine-PEG reacted to GOPTS modified glass, and 




All of the surfaces prepared in this experiment exhibited excellent resistance to 
the nonspecific adsorption of cy3-MsIgG in comparison to that of unmodified glass; 
however, when compared to each other, the various preparation methods resulted in 
significant differences in the amount of adsorbed cy3-MsIgG at the single molecule level, 
as tabulated in Table 2.1.  These results give insight into surface properties at the 
molecular level with respect to preparation methods and immobilized polymer size. 
The highest level of protein adsorption was exhibited by the surface where 2000 
g/mol mPEG-NHS was reacted to the amine-functionality of glass slides modified with 
APTES.  After the incubation with 1 nM cy3-MsIgG and rinse with PBS with 0.1% 
Tween 20 period, 4.1 ± 0.1 pg/cm
2
 (27 ± 1 amol/cm
2
) of cy3-MsIgG remained 
irreversibly adsorbed after rinsing. In direct comparison, the 2000 g/mol mPEG-amine 
reacted to the epoxide functionality of GOPTS-modified glass slides produced the 
greatest resistance to the nonspecific adsorption of cy3-MsIgG.  The 2000 g/mol  mPEG-
amine slides resulted in 0.2 ± 0.02 pg / cm
2
 (1.2 ± 0.2 amol / cm
2
) adsorbed cy3-MsIgG 
remaining bound after the incubation and rinsing period.   Although the APTES modified 
glass slides were reacted from a solution of mPEG-NHS at a concentration that was 100 
times greater than that of the amine-PEG reaction, the epoxy-based PEG-immobilization 
chemistry produced a 25-fold smaller population of adsorbed cy3-mAb.  Considering 
both surfaces were modified with the same molecular weight PEG, the difference in the 
nonspecifically adsorbed cy3-mAb population exhibited by the two preparation methods 
was likely due to differences in PEG surface densities.   
The poorer resistance to mAb adsorption displayed by the N- hydroxysuccinimide 




surface modification amol / cm
2 
Bare Glass >> 200 
2000 MW NHS-PEG 27 ± 1 
750 MW NH2-PEG 18 ± 1 
2000 MW NH2-PEG 1.2 ± 0.1 
Table 2.1: Surface concentration of strongly adsorbed antibody 




ester groups, leading to a lower density of covalently grafted PEG. As the reaction 
progressed over time, the concentration of active NHS-PEG in solution decreased due to 
hydrolysis.  Eventually this grafting reaction prematurely stopped once the N-
hydroxysuccinimide ester completely hydrolyzed.  Simultaneously, as the density of 
covalently immobilized PEG increased on the surface, the rate of aminolysis at the 
surface slowed with time due to steric crowding.
60
 Together these processes limit the 
surface density of the grafted PEG monolayer.  The single molecule images collected 
from the NHS-PEG surfaces shows that the cy3-MsIgG typically nonspecifically 
adsorbed to the surfaces as discrete single-molecule events  (see Figure 2.8).  A smaller 
fraction of sites (~10%) appear to be clusters of adsorbed proteins, whose area exceeds 
the upper confidence bound of the point-spread function of the microscope (>36 pixels
2
). 
The results suggest that the vast majority of the surface is PEG functionalized; however, 
there are isolated molecular scale defects and a smaller population of slightly larger 
defects, where PEG chains are missing and cy3-MsIgG adsorbs as single-molecules or 
clusters, respectively. 
The surfaces prepared from the reaction of PEG-amine to epoxide-modified glass 
also resulted in discrete molecule adsorption sites; however, these surfaces exhibited 25 
times smaller defect densities compared to the NHS chemistry.  Unlike N-
hydroxysuccinimide esters, the reactive epoxide groups of GOPTS modified slides do not 
undergo hydrolysis at alkaline pH.  The higher stability of the reactive epoxide groups 
allows for longer reaction times, which helps overcome the slowed reaction rates caused 
by the steric crowding effect.  By incubating the epoxide slides in a 1 mM amine-PEG 




























































































































































































adsorption of cy3-MsIgG suggests that the epoxide-based chemistry was capable of 
producing a higher density of covalently grafted 2000 g/mol PEG onto the functionalized 
glass slides.  This also suggests that given enough time and the proper chemistry, most of 
the defects sites within the grafted PEG monolayers could be functionalized with PEG 
molecules.   
When considering the ability for epoxy-based chemistry to overcome the slow 
reaction rates of hindered sites, it is important to understand how the molecular weight of 
the grafted PEG affects protein adsorption properties of the PEG modified surface.  In 
comparison to the 2000 g/mol mPEG-amine, the smaller, 750 g/mol, mPEG-amine 
resulted in 3.0 ± 0.1 pg/cm
2
 (18 ± 1 amol/cm
2
) of irreversibly adsorbed cy3-MsIgG, 
compared with the larger (2000 g/mol) amine-PEG, which exhibited 15-times fewer 
defects for adsorption of cy3-MsIgG.  Although it is likely that the surface concentration 
of covalently immobilized PEG is higher in the case of the smaller (750 g/mol) mPEG-
amine, the larger molecular weight PEG was superior at resisting the adsorption of cy3-
MsIgG.  In contrast, the 750 g/mol mPEG-amine resulted in approximately 1.6 times less 
adsorbed cy3-MsIgG compared to the 2000 g/mol mPEG-NHS surfaces, which is likely 
the result of a higher surface concentration and fewer defects in the case of the 750 g/mol 
mPEG-amine.  These findings suggest that there are two issues that control optimal 
resistance to protein adsorption.  First, a stable PEG reagent and intermediate 
functionalized layer are needed to provide ample time for surface defects in the 
immobilized PEG layer to fill in.  This is illustrated by the 750 g/mol PEG-amine being 
able to achieve a grafted PEG layer with fewer defects than the 2000 g/mol PEG-NHS.  
Secondly, the larger exclusion volumes and conformational entropy of longer polymer 
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chains greatly improves the resistance to protein adsorption, as shown by the 2000 g/mol 
PEG-amine being much more resistant to the adsorption of cy-MsIgG compared to the 
750 g/mol PEG amine.  As a result, a PEG modified surface with optimal resistance to 
nonspecific protein adsorption should be composed of a uniform and dense monolayer of 
higher molecular weight grafted PEG chains.  In order to produce such a surface, the 
proper grafting chemistry must be chosen in order to allow adequate time from the 
covalently deposited monolayer to achieve a maximum defect-free density.   
 
2.4 Discussion 
The goal of this research was to better understand how the chemistry used to 
immobilize monofunctional PEG molecules to glass surfaces affects the ability of a 
modified surface to resist the nonspecific adsorption of proteins.  Comparing the reaction 
of N-hydroxysuccinimide active esters of PEG to APTES-modified glass slides and 
amine conjugated PEG to GOPTS-functionalized glass slides, we demonstrated that the 
resistance of the resulting surface to the nonspecific adsorption of proteins is influenced 
by chemistry used to prepare the PEG monolayer.  Both methods produced surfaces with 
excellent resistance to the adsorption of cy3-MsIgG in comparison to unmodified glass 




 of a full monolayer of 
IgG.  At the single molecule level, it was revealed that there were significant differences 
in the degree of nonspecific protein adsorption exhibited by each prepared surface.  The 
epoxide-based chemistry produced surfaces that were up to 25-times more resistant to the 
nonspecific adsorption of cy3-mAb in comparison to N-hydroxysuccinimide ester 
chemistry, thus demonstrating the importance that the immobilization chemistry plays in 
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the surfaces final properties.  Considering the increased resistance observed with the 
epoxide-based chemistry, two different molecular weight (750 g/mol and 2000 g/mol) 
PEG-amine molecules were grafted to the GOPTS modified surfaces and compared.  
Although the 2000 g/mol PEG-amine was ~15-times more resistant to the adsorption of 
cy-MsIgG, the 750 g/mol PEG-amine was 1.6-times more resistant to adsorption 
compared to the 2000 g/mol PEG-NHS modified surface.  From these results it is 
apparent that both the immobilization chemistry and molecular weight of the grafted 
polymer influence the nonspecific adsorption properties exhibited by the modified 
surface.  Because of the stability of epoxide functional groups, the reaction PEG-amine to 
GOPTS modified glass slides achieved a relatively defect-free surface composed of high 
molecular weight PEG.  With the large variety of heterofunctional amine-PEG molecules 
commercially available, epoxide-based chemistry provides a simple and cost effective 
means of producing sensor capture surfaces that are resistant to the nonspecific 
adsorption of proteins. 
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CONTROLLING PROTEIN BINDING SITE DENSITIES ON 
 PEG-MODIFIED GLASS SURFACE 
 
3.1 Introduction 
Controlling the density of covalently immobilized biomolecules at interfaces, 
while simultaneously preventing the nonspecific adsorption of proteins, has increasingly 





 and assays of protein 
therapeutics,
3
 utilize heterogeneous capture assays, where one of the interacting 
molecules is immobilized at a sensor surface.  The selective binding of solution-phase 
analytes to surface-immobilized capture sites directly results in a measured signal from 
optical based microarray techniques such as surface plasmon resonance (SPR), fiber-
optic fluorescence, and total internal reflection fluorescence (TIRF).
4,5
 The ability of a 
sensor to optimally function requires the measurement interface to be resistant to 
nonspecific adsorption of biomolecules; yet simultaneously, the immobilized capture 
proteins must maintain native structure and preserve biological recognition.  Furthermore, 
the capture-site density on a sensor surface directly affects the measured signal response, 
sensitivity, kinetics, and capture activity of the sensor.
6-9
 Thus, the ability for bio-affinity 
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sensors to operate quantitatively and efficiently necessitates the reproducible 
manipulation and optimization of surface properties, including the minimization of 
nonspecific interactions and control over binding-site density. 
Because proteins are composed of a variety of functional domains, they are highly 
surface active and readily adsorb to interfaces through hydrophobic, electrostatic, and 
hydrogen-bonding interactions.
10
 In many cases, the interactions between immobilized 
(covalently bound or passively adsorbed) proteins and their solid supports result in 
conformational changes within their secondary and tertiary structures.  In turn, this leads 
to the denaturation and deactivation of the immobilized receptor protein.
11
 A surface 
must not only be resistant to the nonspecific adsorption of target proteins from solution, it 
must also provide an inert layer that preserves the native bioactivity and structure of the 
immobilized biomolecules.  The surface density of immobilized capture proteins can also 
affect the bioactivity of a sensor.  At high capture-site densities, closely packed 
biomolecules can cause the active domains of the receptor molecule to be inaccessible to 
solution phase analytes.  This effectively deactivates a significant population of 
immobilized capture proteins and decreases the sensitivity and efficacy of the sensor.
7
 It 
becomes clear that the functionalization chemistry used to prepare a capture surface is a 
complicated issue to address.  The surface functionality for an optimal sensor platform 
requires a rigorous set criteria to be fulfilled: (i) the surface must be resistant to the 
nonspecific adsorption of proteins, (ii) the modified surface must not inhibit the activity 
of subsequently immobilized capture proteins, (iii) the chemistry used to functionalize the 
surface must allow for the control of the surface concentration of conjugation sites over a 
wide range, (iv) and the conjugation site linking chemistry must provide a highly 
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selective and easy means to immobilize capture biomolecules.  
Attempts to control the density of covalently immobilized biomolecules to glass 
and other oxide surfaces for sensor applications have been undertaken through variety of 
strategies.  Most commonly, the covalent immobilization of biomolecules on glass-type 
surfaces has been accomplished through deposited organic-silane monolayers.  







 these active monolayers target and react with accessible ε-amines of 
lysine within a protein to form covalent linkages with the surface.  A major disadvantage 
to such methods is that both the immobilization orientation and density of biomolecules 
is uncontrollable and random. In addition, the reactive functionalities of organo-silane 
coatings commonly have poor resistance to nonspecific adsorption of proteins and require 
the addition of blocking agents such as bovine serum albumin (BSA), gelatin, or casein, 




An alternate approach has employed grafted polyethylene glycol (PEG) 
monolayers on glass-type surfaces as a means to better fulfill the requirements for 
optimal sensor surfaces.  PEG coatings have previously been shown to resist the 
nonspecific adsorption of proteins,
18-20
 while simultaneously providing an inert 
foundation to tether biomolecules.
21-23
 The protein repellent properties exhibited by PEG 
monolayers have been attributed to steric interactions between tightly packed PEG 
chains,
24
 high conformational entropies of PEG molecules that define large exclusion 
volumes,
18,20
 and high energy penalties associated with expelling tightly associated water 
molecules in order to allow protein adsorption.
22,25
 The repulsive forces preventing 
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adsorption from occurring also help stabilize the secondary and tertiary structures of 
proteins near the PEG interface.  As a result, proteins immobilized to PEG surfaces have 
shown to maintain a higher degree of bioactivity compared to that of other surface 
functionalities.
18
 The indifferent nature of the PEG layer allows the covalently tethered 
capture biomolecule to exist in a more solution-like state above the surface.  As a result, 
this provides the immobilized protein with an environment that may help preserve native 
properties.  
The tethering of protein capture-sites to PEG monolayers has been accomplished 
through both covalent and affinity-based immobilization strategies.  Hetero- and homo- 
bifunctionalized PEG polymers have been used to covalently link biomolecules onto 
glass surfaces activated with organo-silanes.
26
 Diamino- (DAPEG) and dicarboxy- 
(DCPEG) functionalized PEG polymers have been grafted to 
(Glycidyloxypropyl)trimethoxysilane (GOPTS) functionalized glass slides as a means to 
form functionalized PEG layers that are resistant to the adsorption of proteins.  Activated 
terminal amines or carbonyls of the PEG layer are then reacted to random nucleophilic 
groups in the protein to be immobilized.
27
 In many cases, these activation steps result in 
poor reaction yields and little to no control over the orientation of the immobilized 
biomolecules.  As a result, these methods fail to provide a selective means to immobilize 
capture proteins at a controlled site density and orientation. 
Attempts to gain control over the density of immobilized capture sites within PEG 
layers have utilized mixed-functionality PEG coatings.  Poly(L-lysine)-grafted-
poly(ethylene glycol) (PLL-g-PEG) is known to spontaneously adsorb to glass and other 
negatively charged oxide surfaces at neutral pH, producing PEG coatings that  are 
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resistant to the nonspecific adsorption of biomolecules.
28,29
 By adjusting the ratio of a 
biotin-terminated PEG to mPEG molecules grafted onto the poly(L-lysine)  (PLL) 
backbone, it was shown that the density of subsequent captured streptavidin molecules 
was controllable.
30,31
 Although this method simultaneously fulfills the criteria required 
for optimal sensor functionality, a major limitation of the PLL-g-PEG method is that the 
electrostatic interactions binding PLL-g-PEG to glass surfaces can be disrupted with high 




Despite this disadvantage, the mixed biotin-PEG/mPEG layer was successful at 
controlling conjugation site densities.  Since it was first introduced by Suter et. al,
35
 the 
biotin-(strept)avidin interaction has been extensively used as highly selective means to 
indirectly immobilize biomolecules onto interfaces through a streptavidin intermediate,
36
 
while varying the surface density of (strept)avidin molecules.
30
   With the large variety of 
commercially available biotinylated and biotin conjugation products, the biotin-
(stept)avidin complex provides a flexible means to selectively immobilize biomolecules 
to an interface.  The biotin-(strept)avidin complex is one of the strongest noncovalent 
interactions in nature (Kd= 10
-14
M)  and is stable over a wide variety of pH values and 
temperatures.
37-39
 (Strept)avidin is a homotetramer with four biotin-binding sites that 
allow for multiple biotin containing molecules to simultaneously bind to a single 
(strept)avidin tetramer.
40
 As a result, (strept)avidin is an advantageous intermediate 
building block to immobilizing biotin conjugated biomolecules to interfaces.  
 In this work, a simple means to covalently immobilize heterogeneously 
functionalized PEG monolayers was investigated in order to prepare a surface resistant to 
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the nonspecific adsorption of proteins, inert to interfacially immobilized biomolecule, and 
with control over bioconjugation site density.  As illustrated in Figure 3.1, glass surfaces 
were modified with a uniform GOPTS monolayer using chemical vapor deposition 
(CVD) methods.  Utilizing the high reactivity of nucleophiles towards epoxide-
functionalized surfaces,
27
 amine functionalized poly(ethyleneglycol) (PEG-amine) 
molecules were grafted onto GOPTS modified glass surfaces at high pH.  Discrete 
conjugation sites were created by diluting 2,300 g/mol biotin-PEG-amine at varied 
concentrations into 750 g/mol mPEG-amine to react with the GOPTS-activated surfaces.  
The density of surface biotins was characterized by monitoring the fluorescence of a cy3-
conjugated streptavidin (cy3-streptavidn) binding to the surface-immobilized capture-
sites using total internal reflection fluorescence (TIRF) imaging.  The composition of this 
capture surface resists the nonspecific adsorption of proteins and provides control over 
capture-site densities down to very low fractions (10
-6
) of a (strept)avidin monolayer.  
 
3.2 Experimental 
3.2.1 Reagents and Materials 
 (3-Glycidyloxypropyl)trimethoxysilane (GOPTS), methoxypoly(ethylene glycol) 
amine (mPEG16-amine) with an average molecular weight (Mn) of 750 g/mol, and biotin 
poly(ethylene glycol) amine (biotin-PEG48-amine) with Mn of 2300 g/mol were 
purchased from Sigma Aldrich (St. Louis, MO). Cy3-conjugated streptavidin was 
obtained from Jackson Immunoresearch Laboratories Inc. (West Grove, PA).  The degree 
of cy3 labeling was characterized using a Thermo Scientific (Wilmington, DE)  




Figure 3.1: Reaction of a mixture of biotin-PEG-amine and mPEG-amine to 




were used as received.  Gold Seal microcover glasses (22 X 22mm No. 1.5) were 
purchased from VWR (West Chester, PA).  
 
3.2.2 Surface Derivatization  
The grafting of PEG to glass substrates began with the cleaning of glass cover 
slides by immersion in a freshly prepared solution containing H2SO4 and 30% H2O2 (2:1 
vol) for 20 minutes.  This cleaning step was followed by 6 rinses in 18MΩ-cm H2O.  
Residual surface siloxanes were then converted to silanols by treating the clean glass 
cover slides in a 75C base bath composed of H2O, NH4OH, and 30% H2O2 (5:1:1 vol) 
for 10 minutes.  After treatment with base, slides were rinsed 3 times with 18MΩ-cm 
H2O and dried under a stream of ultra-high purity nitrogen. 
 The formation of an epoxide monolayer on glass cover slides was achieved 
through the deposition of GOPTS from the vapor phase.
41
 A slide holder, containing 10 
vertically racked clean glass cover slides, was placed in a glass vessel containing 500 L 
of GOPTS.  The slide holder was tall enough to completely suspend the cover slides 
above the bottom of the container in order to avoid direct contact with the reactive liquid 
GOPTS.  The reaction vessel was then sealed and then placed in a convection oven, 
previously heated to 60C, for 18 hours.  After the silanization reaction was complete, the 
rack of slides was removed from the container and then further incubated for an 
additional 5 minutes at 60C in an empty oven to evaporate physisorbed GOPTS.  The 
slides were then removed from the oven and allowed to cool to room temperature before 
further derivatization.  
In order to regulate the surface site density of biotin, a mixture of biotin-PEG48- 
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amine and mPEG16-amine was simultaneously reacted with the epoxide-functionalized 
slides.  Five solutions consisting of (0.0, 0.42, 0.83, 1.3 and 1.7 M) biotin-PEG48-amine 
and 1 mM mPEG16-amine in pH 10.1, 100-mM carbonate buffer were prepared. 
Individually, the epoxide functionalized slides were then placed horizontally in the 
bottom of separate 30 ml beakers and covered with 4 ml of the desired reagent solution.  
To ensure each slide was fully submerged, additional reactive solution was added to 
adequately cover each slide as required. The beakers were covered, placed on a titer plate 
shaker, and allowed to react for 18 hours under slow shear mixing.  After the reaction 
period was complete, the slides were then rinsed 3 times in 18MΩ-cm H2O and 3 times in 
20 mM phosphate buffered saline (PBS) at pH 7.5, 100 mM ionic strength.  Slides were 
stored in 20 mM PBS for no longer than 1 week prior to characterization.  
 
3.2.3 Surface Site Density Characterization   





streptavidin was used to characterize the surface site density of biotin for the four 
dilutions of binding sites in the grafted PEG monolayers.   Each slide at the respective 
dilution was assembled into a flow cell and loaded onto an inverted TIRF microscope. 
Each slide was first exposed to flowing (30 ml/hr) 20 mM PBS (pH 7.5, 100 mM ionic 
strength) with 0.1% Tween 20 and illuminated with 12 mW of 532-nm laser radiation, 
measured at the back of the objective, for ~15 minutes in order to photobleach any 
background fluorescence.  All subsequent accumulation and rinse cycles were carried out 
at a flow rate of 30 ml/hr.  A solution of 200-pM (30-ng/ml) cy3-streptavidin was then 
injected onto the sample and incubated for 100 minutes under continuous flow.  After the 
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accumulation was complete, the slides were rinsed with 20 mM PBS with 0.1% Tween 
20 under continuous flow for an additional 100 minutes.  By monitoring the number of 
fluorescent molecules on the surface, it was determined that the accumulation time was 
adequate for the saturation of biotin with streptavidin, and the rinse time allowed 
desorption of weakly associated streptavidin to leave the surface. 
 
3.2.4 Single Molecule Imaging 
The single molecule imaging of cy3-streptavidin was achieved using an Olympus 
IX71 inverted microscope incorporating an in-house built microscope stage outfitted with 
piezoelectric NanoFlex translation stage (ThorLabs), capable of maintaining focus over 
long durations of time (> 5 hours).  The samples were excited using a 532 nm laser 
(B&W TEK Inc.)  operating at 1 mW of power into the objective.  Using a single mode 
fiber launch, the laser light was focused into the back of an Olympus plan apo 60X, 1.45 
NA, oil immersion objective.  Total internal reflection was achieved by translating the 
incoming light off center into the objective.  The emitted fluorescence was then collected 
back through the same objective, passed through a 552 nm BrightLine dichroic 
beamsplitter (Semrock) and a 585/40 nm BrightLine bandpass filter (Semrock), and then 
imaged using an Andor iXon+ CCD camera.  TIRF images were acquired using Andor  
IQ software at 200 ms integration times.  Image processing to count individual cy3-







3.3.1 Formation of PEG Surfaces 
By diluting biotin-PEG-amine into a 750 g/mol mPEG-amine monolayer, a 
surface that is resistant to the nonspecific adsorption of protein is generated, while 
providing control over the bioconjugation site density.  The grafting of PEG monolayers 
was accomplished through the nucleophilic substitution of PEG-amine to the epoxide 
functionality of a GOPTS-modified glass slide.  Due to the relatively high stability of 
epoxides in aqueous solutions at neutral pH or above and their high reactivity with 
primary amines at high pH conditions,
27,42
 epoxy-based chemistry provides a simple 
means to control conjugation site density during the formation of mixed PEG 
monolayers.  The production of highly uniform epoxy functionalized monolayers was 
accomplished through the deposition of GOPTS out of the vapor phase.
41,42
   Heating this 
reaction to 60C for 18 hours promoted a high GOPTS vapor pressure allowing the 
deposition of alkyl silane to occur.  
The immobilization scheme depicted in Figure 3.2 illustrates the chemistry used 
to form a mixed functional PEG (mPEG16 and biotin-PEG48) monolayer through the 
reaction between amine terminated PEG polymers and epoxide-functionalized glass 
surfaces. The zero binding site mPEG16-amine grafted glass surfaces had sufficient 
resistance to the nonspecific adsorption of streptavidin, and resulted in a nonspecifically 
adsorbed population of streptavidin at 10
-9





from a 200 pM (30-ng/ml) solution, shown in Figure 3.2.   
By using a longer chain tether length (biotin-PEG48-amine), the biotin conjugation 




Figure 3.2: Nonspecific polulation of streptavidin remaining 
strongly adsorbed to 750 g/mol PEG surface containing no biotin- 




hindered or engulfed by the surrounding polymer chains.  By grafting a mixed monolayer 
from a solution containing a dilute concentration of biotin-PEG48-amine (0.42-1.7 M) 
and a much higher mPEG16-amine concentration (1 mM), a surface resistant to the 
nonspecific adsorption of biomolecules, yet containing a low density of biotin sites, was 
produced.  Achieving a conjugation site density near 10
-6 
of a fraction of a streptavidin 
monolayer allows the conjugation sites to be separated by micron distances, and the 
bound (strept)avidin intermediates can easily be resolved within the diffraction limits of 
optical microscopy.  By adjusting the ratio of biotin-PEG48-amine and mPEG16-amine 
contained within the reaction solution, the surface concentration of biotin conjugation 
sites was controlled, allowing for the optimization of a sensor response to suit the 
requirements of a given technique.  
 
3.3.2 (Strept)avidin Labeling of Biotin Conjugation Sites 
The tethering of biotin-labeled biomolecules to surfaces through (strept)avidin 
intermediates has commonly been employed as a means to immobilized antibodies, 
enzymes, and cells to interfaces.
35,43,44
 In order to measure the interactions between 
individual biomolecules at a single-molecule level, it is important to control biotin 
surface sites down to very small fractions (10
-6
) of a (strept)avidin monolayer.  In this 
study, the biotin site density within the grafted diluent PEG monolayer was characterized 
using single-molecule imaging of cy3-streptavidin.  Its relatively low nonspecific 
adsorption properties, likely due to its near-neutral isoelectric point, and high affinity for 
biotin-conjugates makes streptavidin an ideal intermediate to immobilize capture proteins 
to sensor platforms.
40
   To assay the streptavidin capture, the biotinylated cover slides 
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were loaded into a flow cell, illuminated with 532 nm laser radiation, and allowed to 
photobleach for 15 minutes.  The slides were then exposed to 2  10-10 M cy3-labeled 
streptavidin.  A concentration of streptavidin >20,000-times greater than the Kd was used 
in order to ensure the complete saturation of available biotin binding sites.   
Assessing the time required for cy3-streptavidin to completely saturate the biotin 
surface sites was achieved by collecting an image once every 10 minutes by exposing the 
sample to 200 ms of laser light.  By intermittently imaging over the duration of the entire 
experiment, the photobleaching of the fluorescent cy3 dye conjugated to streptavidin was 
minimized, where the total exposure time over the entire course of the experiment was 
3.6 seconds, which is <2% of the photobleaching time observed under continuous 
illuminations (see previous chapter).  Monitoring of the accumulation and rinsing of cy3-
streptavidin, as shown in Figure 3.3, revealed that 1 hour was sufficient time to reach 
equilibrium; however, flow of cy3-streptavidin was maintained for an additional 1 hour 
to allow all biotin-streptavidin complexes to assemble.  The desorption of weakly 
associated streptavidin molecules from the surface by rinsing for 2 hours produced a 
constant surface site density of strongly bound streptavidin.  Even after 60 hours under 
continuous flow of rinse buffer in the absence of laser excitation, the capture slide 
showed < 20% decrease in the immobilized streptavidin surface population. At micron 
distances between surface biotin sites, the strongly-bound complex formed by the 
streptavidin-biotin interaction is not the result of bivalent interactions or rebinding to 
nearby biotin sites.
45
 As a result, the interfacial complex formed by a single streptavidin 
and a single biotin appears to be irreversible on the time scale of ≥24 hours,46 which 





~ 20% loss after 
60 hours 
Figure 3.3: Accumulation of 200 pM cy3-streptavidin 
and wash from 750 g/mol PEG surface containing a 




subsequently investigated protein-protein interactions on sensor platforms. 
After establishing the required accumulation/rinse times, the biotin surface site 
density was characterized, on separate slides, by 2 hours of exposure to 2  10-10 M cy3-
labeled streptavidin, followed by 2 hours of rinsing with buffer.  Each accumulation/rinse  
cycle was conducted in the absence of light as a means to avoid any photobleaching of 
the cy3- labels covalently attached to each streptavidin molecule.  At the end of the cycle, 
the slides were immediately imaged using TIRF microscopy.  The fluorescence from 
interfacially bound cy3-streptavidin had an average intensity S = 52 photoeletron counts, 
with a spot-to-spot variation in peak intensities having a standard deviation σS = 11 
photoelectons.  The large variation in streptavidin-to-streptavdin intensity most likely 
arises from differences in the number of cy3-labels carried by each individual 
streptavidin molecule, where the average streptavidin was labeled with 3.7 ± 1.9 cy3 
molecules.  The threshold for counting single-molecule surface sites was determined 
from the background intensity and noise level of the biotinlylated slides after 
photobleaching, but prior to exposure with cy3-labeled streptavidin.  The average 
background level was measured to be B = 10 photoelectrons counts, with a variation in 
pixel-to-pixel background counts having a standard deviation of σB = 2 photoelectrons.    
The threshold for counting cy3-labeled molecules, shown in Figure 3.4, was set such that 
a spot >4 pixels
2
 in area have an average pixel intensity 10 times σB above B at 30 
photoelectrons, meaning the probability of false positives arising from fluctuations in the 
background was negligible.     
 Quantifying the biotin site density was accomplished by counting the number of 






Figure 3.4: Histogram of background pixel intensities fit to an exponentially 
modified Gaussian distribution (red) and the intensity of individual cy3-
MsIgG spots, adsorbed to a PEG modified surface, fit to an exponentially 
modified Gaussian (black) distribution.  The dashed line sets the threshold 
for counting single molecules. 
  
85 
field of view, as illustrated by Figure 3.5.  Images from each of the four biotin-PEG-
amine dilutions including a “blank” surface containing no biotin-PEG revealed a 
monotonic increase in streptavidin surface concentration, as demonstrated by the images 
in Figure 3.6 and the tabulated data in Table 3.1.  The relationship between the biotin-
PEG dilution ratio and the streptavidin binding site density was linear and was evaluated 
using a linear least-squares fit. As plotted in Figure 3.7, the slope was determined to be 
0.79  0.04 nmols/m2, for a single lot of slides, with a 0.29 0.02 amols/m2 intercept that 
corresponds to the zero-binding site, blank slide.  While the site density varies linearly 
with the biotin-PEG concentration within a given lot, there is up to a ~30% variation in 
slope between separately prepared lots of slides.  
In order to test whether the incorporation of biotin-PEG into the monolayer is 
stoichiometric, the surface density of the 750 g/mol PEG diluent can be estimated from 
its radius of gyration, which has been measured to be ~0.9 nm.
47
 If the surface 
immobilized 750 g/mol PEG adopts a spherical conformation equivalent to its radius of 
gyration in solution, then the grafted surface concentration for a monolayer of PEG 
would be ~4.7 nmols/ cm
2
.  The density of the biotin-PEG, extrapolated from the results 
in Figure 3.7 to 100% biotin-PEG in the reaction solution, is 0.79  0.04 amol/cm2.  This 
is ~600-times lower than the expected surface concentration predicted by the 
stoichiometric ratio of the biotin-PEG in a monolayer of the 750 g/mol mPEG diluent.  
The lower than expected value observed for density of biotin conjugation sites in 
the PEG monolayer may arise from several possible origins.  One likely cause would be 
the difference in reaction rates of the two PEG molecules.  The surface grafting of linear 







Figure 3.5: Located single cy3-streptavidin molecules 








a “blank” 0.29 ± 0.02 
b 0.4 × 10
-3
 35 ± 3 
c 0.8 × 10
-3
 62 ± 2 
d 1.3 × 10
-3
 95 ± 2 
e 1.7 × 10
-3
 140 ± 10 
Table 3.1: Surface concentration of cy3-streptavidin captured 
by biotin conjugation sites for each dilution.   

















































































































































Figure 3.7: Biotin-PEG conjugation site density as a function of 




-amine.  The 
slope of the fitted line: 0.79 ± 0.04 amol/cm2. 

















Access to the surface by a terminal reactive group is inhibited by collisions with the 
surrounding polymer structure on the surface. This steric reaction rate inhibition is more 
significant with higher molecular weight polymers, where the probability of a reactive 
collision decreases with increasing interference by the surrounding polymer.
49
 This trend 
would predict that the reactive amine groups of the 2300 g/mol biotin-PEG-amine would 
experience a much smaller fraction of collisions, leading to reactions with surface 
epoxide groups, than the 750 g/mol diluent PEG-amine.  Furthermore, the larger 
molecular weight polymer would exhibit slower diffusion in solution and collide with the 
surface less frequently.  Finally, surface binding of the larger, biotin-carrying PEG would 
be further inhibited as the coverage of the 750 g/mol diluent PEG increases and fills in 
the surface,
50
 where the remaining small residual areas might only be accessible to the 
small Mn PEG.  
In addition to the effect of the slower reaction rate of the biotinylated PEG, some 
surface-immobilized biotin may be inaccessible.  Well solvated PEG chains covalently 
immobilized to interfaces have been shown not to adopt an extended brush-like 
conformation, but collapsed mushrooms.
51
 It is possible that some biotin capture sites are 
within these collapsed structures and therefore inaccessible to solution phase streptavidin 
molecules.  The relatively slow accumulation rates observed for streptavidin binding to 
surface immobilized biotin conjugation sites during the accumulation experiments would 
suggest that the accessibility of an individual biotin site might dynamically evolve over 
time.  The small biotin molecules on long PEG tethers are likely distributed between 
residing polymers chains, in an inaccessible state, or being accessible to solution. 
Therefore, some loss of binding site density might arise from the existence of an 
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inaccessible population of biotin conjugation sites that are irreversibly buried within the 
polymer layer.  Unlike a large protein, biotin is a small hydrophobic molecule that is 
capable of accessing and interacting with the underlying functionalized glass surface.  
The biotin population that is accessible to streptavidin binding produces a bioconjugate 
interaction that is irreversible on the timescale of a day.
46,52,53
 
The capture surfaces produced in this experiment simultaneously fulfill the 
criteria earlier discussed for an optimal sensor platform. The PEG surface functionality 
exhibits sufficient resistance to the nonspecific adsorption of proteins while providing a 
means to control conjugation site densities down to 10
-6
 fractions of a streptavidin 
monolayer.  By adjusting the concentration of 2300 g/mol biotin-PEG-amine in a 1 mM 
solution of 750 g/mol mPEG-amine, the density of biotin conjugation sites was readily 
controlled.  The relationship between the ratio concentration of 2300 g/mol biotin-PEG-
amine in the reaction solution and the counted cy3-streptavidin molecules per unit area 
was linear.  Furthermore, the surface density of the immobilized streptavidin molecules 
was well resolvable with optically based fluorescence imaging, potentially allowing these 
surfaces to be used for single molecule investigation of individual protein-protein 
interactions.  The streptavidin-biotin interaction is a highly specific, yet generic means to 
surface immobilize any biotin conjugated protein for a day or more. By first 
immobilizing fluorescently labeled streptavidin molecules, individual conjugation-site 
positions could first be localized and then photo-bleached.  Upon further conjugation 
with any biotinylated-protein, the locations of the streptavidin-biotin-protein pair could 
be colocalized defining active binding sites, in which subsequently investigated 
interactions could be referenced. Because PEG does not completely eliminate the 
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nonspecific adsorption of proteins to interfaces, the use of colocalization diminishes the 
need to fully prevent nonspecific interactions.  By referencing measured spots to known 
binding sites, specific and nonspecific interactions can be discriminated from each 
another.   
 
3.4 Discussion 
The goal of this research was to produce a sensor capture surface that resisted the 
adsorption of nonspecific biomolecules, while maintaining the ability to control the 
density of bio-conjugation sites on glass slides.  Furthermore, the surface 
functionalization process provided a simple means to selectively immobilize capture 
proteins.  The 750 g/mol PEG-amine surface was highly resistant to the nonspecific 
adsorption of streptavidin, amongst other proteins, from aqueous solutions.  The 
conjugation site density was uniformly controlled down to very low fractions (10
-6
) of a 
streptavidin monolayer by diluting in biotin-PEG-amine into an mPEG-amine monolayer.  
At such low densities, the discrete conjugation sites are spaced out over micron distances 
between adjacent molecules, which were easily resolvable using single-molecule 
fluorescent imaging. Using cy3-streptavidin molecules, the linear relationship between 
biotin-PEG-amine reaction solution concentration and the surface site density of 
immobilized biotin was established.  It was possible to control the density of biotin 
conjugations sites on glass surfaces by adjusting the concentration of biotin-PEG-amine 
in a 1 mM mPEG-amine reaction solution.  Using the biotin functionality for conjugation 
sites, these surfaces are able to further employ the well-developed biotin-(strept)avidin 
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interaction as an intermediate tether to selectively immobilize subsequent biotin-
conjugated capture proteins. 
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PROTEIN CAPTURE ACTIVITY AT SOLID-LIQUID INTERFACES 
 
4.1 Introduction 
 Since the enzyme-linked immunosorbent assay (ELISA) was first introduced in 
1971, solid phase immunoassays have become one of the most widely used tools for 
clinical diagnostics and immunosensing applications.
1-4
 Surface-immobilized antibodies 
serve as the foundation for heterogeneous-type immunoassays owing to their high 
specificity toward a wide variety of biologically relevant molecules.  The fundamental 
principle behind such measurements relies on the ability of immobilized capture 
antibodies (CAbs) to efficiently bind homologous antigens (Ags) from solution.  The 
measured signal obtained from “sandwich-type” immunoassays is commonly the result of 
subsequently captured biomolecules, where the compounded activity from each capture 
step governs the amplitude and sensitivity of the observed immunosensor response.
5-7
 In 
many cases, capture proteins immobilized at solid surfaces exhibit a significant decrease 
in observed activity compared to that in free solution, which decreases the efficacy of the 
sensor.
8
 This reduction in bioactivity has been attributed to two primary phenomena.  
First, surface induced alterations of the secondary and tertiary structures of interfacially 





 Second, the orientation of an immobilized protein with respect to the 
plane of the capture surface can be such that the active domain(s) of the protein are 
inaccessible to solution phase antigen/hapten molecules.
12
 With respect to both 
mechanisms of deactivation, the decreased activity associated with interfacially 
immobilized proteins is not fully understood at an individual molecule level.  As a result, 
there is a need to better understand the fundamental processes that govern interfacial 
protein activity at the molecular level in order to produce immunosensor capture surfaces 
with higher sensitivity and lower limits of detection. 
Several procedures have been used to immobilize capture-antibodies onto solid 
supports for immunosensing applications.  Despite the overwhelming evidence indicating 
that protein-surface interactions promote structural and functional changes in surface-
immobilized proteins,
13-16
 passive adsorption techniques remain one of the most 
commonly used methods to deposit capture antibodies onto solid supports.
1,17,18
 It has 
previously been shown that ~75% of polyclonal antibodies (PoAb) physically adsorbed to 
solid surfaces are rendered inactive and are incapable of capturing homologous 
antigens.
11
 Antibodies have also been immobilized covalently to amino- and carboxyl-
modified surfaces using chemical linkers, such as N-hydroxysuccinimidyl ester and 
glutaraldehyde through random accessible lysines contained within the protein.
19
 For 
both passively and covalently surface immobilized antibodies, inefficient capture 
activities are observed, which have been attributed to surface induced structural changes 
within the active domains of the capture protein.
20,21
   
In an attempt to circumvent direct contact with solid surfaces, CAbs have been 
immobilized at interfaces using noncovalent bioaffinity docking through intermediate 
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protein-tethers.  Butler et al. used species-specific antiglobulins as a means to 
immobilized CAbs onto polystyrene surfaces.
22
 In numerous cases, CAbs immobilized to 
surfaces through intermediate antiglobulins showed >100% surface activity, indicating 
the existence of a population of bivalently active capture antibodies; however, the 
efficiency of the surface-immobilized antiglobulins capturing homologous-IgG molecules 
was extremely poor in most cases.  The compounded capture capacity (total apparent 
activity) of the two-step immobilization strategy was only comparable to the activity 
associated with the direct passive adsorption of the capture antibody.
11
    
Strept(avidin), a homotetrameric protein that selectively binds biotin with an 
extremely strong affinity,
23
 has also been used as an intermediate protein tether to bridge 
biotinylated-molecules to interfaces.  Since first being proposed in 1986,
24
 the protein-
avidin-biotin-capture (PABC) method has been extensively used in a variety of 
immunosensor applications.
25-29
 Similarly to antiglobulins, the PABC method showed a 
significant increase in antigen capture capacity for monoclonal antibodies (MoAbs) that 
were immobilized, but again, the efficiency of surface-immobilized strept(avidin) for 
capturing biotinylated-CAbs was quite low.
11,30
 Under optimal conditions, substantially 
more CAbs could be immobilized using physical adsorption techniques.
18,24
  
Despite these inefficiencies, the strept(avidin)-biotin bridge has proven to provide 
many other advantages, over passive adsorption techniques, as a means to immobilize 
proteins to solid interfaces.  Passive adsorption techniques rely on hydrophobic, 
electrostatic, and hydrogen bonding surface/protein interactions to adsorb biomolecules at 
a surface; as a result, the properties associated with such techniques vary greatly from 
surface-to-surface and protein-to-protein.
31
 In some cases, proteins will not 
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spontaneously adsorb to a given solid surface, which renders passive adsorption 
techniques as not a viable option.  In addition, controlling the surface concentration of 
passively adsorbed proteins can be an extremely difficult task, yet the density of surface 
capture sites can greatly affect the activity, measured signal, and sensitivity of a 
sensor.
32,33
 In contrast, the PABC method provides a reproducible means to immobilize 
any biotinylated-biomolecule to a solid interface.
34
 Described in the previous chapter as 
well as by other researchers, the surface concentration of subsequently immobilized 
streptavidin molecules has been shown to be controllable by adjusting the ratio of 
biotinylated-PEG and mPEG molecules deposited onto glass substrates.
25,26
  
Regardless whether the interfacially immobilized CAbs are in direct contact with 
the surface or spaced above the surface through an intermediate protein tether, the 
measured capture efficiency is always much less than theoretically achievable.
11
 It has 
been suggested that surface-induced structural changes are not exclusively responsible for 
the decreased activity.  It has also been hypothesized that the orientation of immobilized 
CAbs with respect to the solution interface could influence the activity of the sensor.
35
 
The molecular basis of most immunoassays is the macromolecule immunoglobulin G 
(IgG), which is composed of two identical “heavy” polypeptide chains that pair with two 
identical “light” polypeptide chains to form the well-known Y-shape structure.  The IgG 
molecule contains two identical variable regions (Fab) that bind antigens with extremely 
high specificity and a constant region (Fc) that regulates effector functions.
36
 Because of 
this asymmetric shape, surface immobilized IgG molecules can have varying degrees of 
antigenicity depending on their orientation with respect to the interface.
37
 In all of  the 
previously discussed CAb immobilization strategies (passive adsorption, direct covalent 
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binding, and indirect protein bridging), the deposition results in random uncontrollable 
distribution of antibody orientations with respect to the surface.  In such cases, a 
significant fraction of CAbs can be oriented in such a manner that one or both of the Fab 
domains are hindered by the surface and inaccessible to solution phase antigens. This 
distribution of orientations could result in severe heterogeneity in activity between 
individual CAbs on the surface.  
Since it was first applied to immunoassays in 1978,
38,39
 protein A, derived from 
Staphyloccus aureus, has become one of the most commonly utilized methods to 
noncovalently immobilize IgG molecules onto solid surfaces in a more controlled 
orientation. 
40-42
 Protein A, as well as protein G and protein A/G specifically bind the Fc 
region of the IgG molecule for a variety of species of vertabrates.
43
 Surface immobilized 
CAbs tethered through Fc binding protein intermediates are aligned with both (Fab’)2 
extended away from the plane of the surface.  In such an orientation, both Fab domains 
are accessible to solution and could simultaneously bind homologous Ags.  Chung et al. 
utilized the PABC method to sequentially immobilize NeutrAvidin, biotinylated-Protein 
A, and donkey-derived antihuman IgG (anti-hIgG) onto gold surfaces.  Immobilized 
through the Fc domain, the efficiency of surface-tethered anti-hIgG capturing hIgG was 
~3-fold greater than a single layer of passively adsorbed anti-hIgG.
29
 Although it is well 
documented that the use of protein A increases surface immobilized CAb activity, the 
capture efficiency of protein A has not been studied at the single-molecule level.  
The activities of surface immobilized antibodies deposited using passive 
adsorption, covalent attachment, and intermediate bioaffinity tethering have been 
investigated using a variety of techniques, including radiometry,
1,8,17,44









 and quartz crystal microbalance 
(QCM).
10,50,51
 These methods produce ensemble signals that report the activities of the 
entire surface population.  Little information is revealed about the distribution of 
activities from site-to-site, and yet the response of multipart immunoassays resulting from 
the sequential immobilization of strept(avidin), biotinylated-protein A, CAb, Ag, and 
reporter-Ab’ can be extremely complex.  For each additional layer, an individual surface-
immobilized capture-protein can be the result of either a specific ligand-receptor 
interaction or nonspecific surface adsorption; therefore, for a system with N layers, there 
are N possible configurations for a surface immobilized capture-antibody as illustrated in 
Figure 4.1.  In addition, each possible complex potentially has differing activities,
22,29
 
causing the combined apparent activity to be composed of a highly complex subset of 
activities.  Although well studied at a macroscopic level, little has been reported about the 
activities of solid-phase immunoassays at the single-molecule level.  
In this work, we applied single-molecule imaging, based on total internal 
reflection fluorescence (TIRF) microscopy, to address molecular-scale issues associated 
with the observed activities for solid-phase immunosorbent assays at site-to-site 
resolution.  A (polyethylene)glycol modified glass surface containing biotin binding sites 




) of cy3-labeled streptavidin 
molecules.  Cy3-conjugated antigoat IgG (anti-GtIgG-cy3) was immobilized to the 
modified-surfaces using four techniques: (i) passive adsorption to an mPEG-modified 
surface, (ii) indirect bioaffinity tethering with streptavidin, (iii) sequentially with 
streptavidin and protein A, (iv) and a one-step deposition of a chimeric (protein A-anti-




Figure 4.1: Sandwich capture assay with N capture steps had N possible 
conformations.   
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sequentially exposed to GtIgG, and the capture activity for each surface preparation was 
measured at the single-molecule level using sequential colocalization.  The compounded 
capture activities were then compared for each of the four methods of immobilization.  
The results demonstrate the inefficiency of interfacially immobilized proteins in 
recognizing their homologous counterparts; however, depending on the method by which 




4.2.1 Chemicals and Materials 
(3-Glycidyloxypropyl)trimethoxysilane (GOPTS), methoxypoly(ethylene glycol) 
amine (mPEG16-amine) with an average molecular weight (Mn) of 750 g/mol, and biotin 
poly(ethylene glycol) amine (biotin-PEG48-amine) with a Mn of 2300 g/mol were 
purchased from Sigma Aldrich (St. Louis, MO) and used as received.  Rabbit antigoat 
IgG(H+L) (anti-GtIgG), goat IgG (GtIgG), and cy3-conjugated streptavidin (cy3-
streptavidin) were obtained from Jackson Immunoresearch Laboratories Inc. (West 
Grove, PA).  Recombinant Protein A from E. coli (EpA) and EZ-link NHS-PEG4-biotin 
were purchased from Thermo Scientific (Rockford, IL).  Cy3 monoreactive N-
hydroxysuccinimidyl ester was purchased from GE Health Care Life Sciences (UK).  
Gold Seal microcover glasses (22 X 22mm No. 1.5) and 10 kDa cutoff Pall Life Sciences 





4.2.2 Protein Labeling 
The monofunctional labeling of anti-GtIgG, GtIgG, and EpA with biotin and cy3 
functional tags was accomplished using succinimidyl ester linking chemistry as outlined 
by Hans et al.
52
 For hetero-bifunctional labeling of anti-GtIgG and EpA simultaneously 
with cy3 and biotin, the protocol was adapted as follows:  Biotin-PEG4-NHS (2 mg) was 
dissolved in 500 L of pH 8.3 carbonate buffer (6.8 mM), Cy3-NHS (1 mg) was 
dissolved in 200 L of DMF (6.5 mM), and 3.33 nmol of each respective protein was 
dissolved in 500 l (6.7 M) of pH 8.3, 100 mM carbonate buffer.  5.5 l (75 M) of the 
biotin-PEG4-NHS and 5.7 l (75 M) of the cy3-NHS containing solutions were the 
added to the protein solution.  The mixture was slowly vortexed at room temperature and 
in the absence of light for 30 minutes.  After the reaction was complete, the free 
dye/biotin was separated from labeled protein solution using 10 kDa cutoff nanosep 
centrifugal dialysis filters.  The labeled protein solution was centrifuge filtered at 10,000 
rpm with 20 mM phosphate buffered saline (pH 7.5, 100 mM ionic strength) until 
negligible fluorescence at 550 nm was detected in the supernatant.   
 
4.2.3 Measurement of Protein and Degree of Dye Labeling 
The protein concentration and dye-to-protein ratio (D/P) for each protein was 
determined using UV-vis absorption measurements at 280 nm and 550 nm in conjunction 













 for protein A).
52
 Because biotin-PEG4-NHS 
and cy3-NHS solutions were prepared and reacted simultaneously and biotin-PEG4-NHS 
has an estimated ~25% faster diffusion coefficient compared to cy3-NHS based on 
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molecular weight, it is expected that the degree of biotin labeling was slightly greater 
than that of cy3, assuming the NHS reactivity of the two reagents are equivalent.  
 
4.2.4 Surface Preparation   
Glass cover slides were first cleaned by immersion into a freshly prepared mixture 
of H2SO4 and 30% H2O2 mixture (2:1 vol) for 20 minutes followed by extensive rinsing 
in 18MΩ-cm H2O.  The clean slides were then treated in an H2O, NH4OH, and 30% H2O2 
mixture (5:1:1 vol) at 75C for 10 minutes; after which, the slides where rinsed 3 times 
with 18MΩ-cm H2O and dried under a stream of ultra-high purity nitrogen.  The 
unmodified glass slides were totally hydrophilic after the cleaning process, such that 
water spreads and results in a nonmeasurable water contact angle. 
 In order to achieve a uniform reactive monolayer, GOPTS was deposited out of 
the vapor phase.
53
 Ten clean glass cover slides were vertically racked into a ceramic slide 
holder and placed into a glass vessel containing 500 l of GOPTS.  The glass vessel was 
then sealed and incubated for 18 hours in a convection oven previously set to 60C.  
After the silanization periods concluded, the slides were removed from the container and 
further incubated in an empty oven for an additional 5 minutes at 60C in order to 
remove physisorbed GOPTS and to prevent residual gas phase GOPTS from condensing 
on the slide’s surface.  The slides were then allowed to cool to room temperature before 
further derivatization occurred. 
 The reaction of PEG-amine to GOPTS modified surfaces utilized the high 
reactivity of epoxide functional groups with primary amines at high pH.  A solution 
containing 100 mM mPEG16-amine and 1 M biotin-PEG48-amine in pH 10.1 carbonate 
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buffer was prepared.  Each epoxide functionalized cover slide was separately placed 
horizontally in the bottom of a 30 ml beaker and covered with 4 ml of the mPEG/biotin-
PEG solution.  If any slide was not fully wetted and submerged, additional reaction 
solution was added.   The beakers were then placed on a titer plate shaker, covered, and 
slowly mixed under orbital shear for 18 hours at room temperature.  After completion, the 
slides were washed three times with 20mM phosphate buffered sailine (PBS) at pH 7.5, 
100 mM ionic strength).  The PEG-modified cover slides were stored up to 1 week in 
PBS prior to their characterization.    
 
4.2.5 Streptavidin Surfaces 
For each immunoassay experiment, the biotinylated capture surface was first 
assembled into a 4 l flow cell and loaded onto an inverted microscope stage.  The 
sample was then rinsed with 20 mM PBS (pH 7.5, 100 mM ionic strength) with 0.1% 
Tween 20 and illuminated with 12 mW of 532-nm laser radiation.  In order to remove all 
inherent background fluorescence, the sample was photobleached for 15 minutes prior to 
any surface modification.  A streptavidin-modified surface was prepared by treatment of 
a photobleached biotin-modified slide with 11 ng/ml (200 pM) cy3-streptavidin in PBS.  
Under continuous flow (30 ml/h), the sample was incubated for 120 minutes with the 
streptavidin containing solution and then rinsed with PBS (0.1% Tween 20) for an 






4.2.6 Anti-GtIgG Surface 
Prior to the injection of each additional protein layer, the sample was 
photobleached for 15 minutes using 12 mW of 532-nm laser radiation.  Biotin-anti-
GtIgG-cy3 at a concentration of 75 ng/ml (500 pM) in PBS was injected onto a 
photobleached streptavidin-modified surface.  The sample was treated for 120 minutes 
and then rinsed with PBS (0.1% Tween 20) for an additional 60 minutes under 
continuous flow (30 ml/h).  After photobleaching the previously immobilized biotin-anti-
GtIgG-cy3 layer, 75 ng/ml (500 pM) GtIgG-cy3 in PBS was accumulated under 
continuous flow for 120 minutes and rinsed for 60 minutes with PBS (0.1% Tween 20).   
 
4.2.7 Protein A-anti-GtIgG Surface 
A photobleached streptavidin-modified slide was sequentially exposed to 10 
ng/ml (250 pM) biotin-EpA-cy3, 75 ng/ml (500 pM) anti-GtIgG-cy3, and 75 ng/ml (500 
pM) GtIgG-cy3 in PBS.   Prior to the injection of each subsequent protein layer, the 
sample was photobleached with 12 mW of 532-nm laser radiation for 15 minutes.  Each 
protein was accumulated under continuous flow (30 ml/h) for 120 minutes followed by 
60 minutes of rinsing with PBS (0.1% Tween 20).   
 
4.2.8 Protein A-anti-GtIgG Chimeric Complex Surface 
The single step immobilization of the protein [EpA/anti-GtIgG] chimeric complex 
was accomplished by first pre-equilibrating 6 g/ml (125 nM) of biotin-EpA  and 75 
g/ml (500 nM) anti-GtIgG-cy3  in 20 mM PBS ex situ for 1 hour.  The chimera 
containing solution was diluted by 500 times and injected onto a photobleached 
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streptavidin-modified slide.  The chimeric complex was accumulated under continuous 
flow (30 ml/h) for 120 minutes and then rinsed with PBS (0.1% Tween 20) for 60 
minutes.  After photobleaching the immobilized chimeric complex with 12 mW of 532-
nm laser radiation for 15 minutes, 75 ng/ml (500 pM) GtIgG-cy3 in PBS was then 
injected, accumulated for 120 minutes, and rinsed with PBS (0.1% Tween 20) for an 
additional 60 minutes.    
 
4.2.9 Single Molecule Imaging 
The fluorescent imaging of cy3-labeled proteins used for monitoring each 
immunoassay step was achieved using an Olympus IX71 inverted microscope retrofitted 
with an in-house built stage utilizing a piezoelectric NanoFlex translation stage 
(ThorLabs), capable of maintaining focus over many hours of observation.  The cy3-
labeled proteins were excited with 1mW, measured at the back of the objective, of 532 
nm laser (B&W TEK Inc.) light.  The laser was coupled into a single mode fiber and 
launched off-center into the back of an Olympus plan apo 60X, 1.45 NA, oil immersion 
objective to achieve total internal reflection.  Emitted fluorescence was then collected 
back through the same objective, passed through a 552 nm BrightLine dichroic 
beamsplitter (Semrock) and 585/40 nm BrightLine bandpass filter (Semrock), and 
imaged using an Andor iXon+ CCD camera.  
The accumulation and rinse of each sequentially deposited protein layer was 
monitored using total internal reflection fluorescence (TIRF) by intermittently collecting 
images every 10 minutes at 150 mseconds integration times.  Each accumulation was 
monitored for 12 image cycles (120 minutes) and then rinsed for an additional 6 image 
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cycles (60 minutes).  This was sufficient time to reach saturation and desorption of 
weakly-bound proteins, while minimizing the photobleaching of any conjugated cy3 
label.  At the end of each accumulation/wash cycle, 5 images were acquired at 20-
seconds intervals and 150 mseconds integration times.  The 5 images were then imported 
into image J,
54
 where they were co-added and analyzed.  The fluorescent background 
measured for 5 coadded images obtained from a photobleached surface prior to the 
accumulation of protein had an average intensity of B = 103 photoelectron counts, while 
having a variation in pixel-to-pixel intensity of σB = 13 photoelectrons.  The threshold for 
counting single molecules, plotted in Figure 4.2, was set such that a spot >4 pixels
2
 in 
area have an average pixel intensity 10 times σB above B at 233 photoelectrons.  Each 
spot above threshold was then fit to a point spread function and its center of mass was 
plotted.  For sequential images from a single accumulation, the average frame-to-frame 
variation in plotted locations, over 180 minutes, had a radius σr = 0.5 pixel.  For each 
capture experiment, the location of subsequently adsorbed protein pairs were plotted on 
top of each other, where the threshold radius for colocalization was set 6.4 times σR, Rc = 
3 pixels.  Under these conditions, the probability of missing a colocalized molecule was 
0.001 based on 2-D Gaussian distribution. The positions of sequentially immobilized 
protein layers were plotted on top of each other using Microsoft Excel (Redmond, WA).  
Subsequent positions were colocalized within an 0.5 μm radius of overlap and then 








Figure 4.2: Histogram of background intensity (black) fit to a 
Gaussian distribution and histograms of individual (green) biotin-
antiGtIgG-cy3, (blue) biotin-EpA-cy3, and (red) GtIgG-cy3 intensities 
each fit to an exponentially modified Gaussian function.  The dashed 




4.3.1 Protein Labeling and Counting 
The average dye-to-protein ratio (D/P) was measured for each labeled protein.  
When labeling with cy3, polyclonal goat IgG (GtIgG-cy3) had an average D/P of 4.4 and 
rabbit antigoat (anti-GtIgG-cy3) had an average D/P of 3.7.  With respect to the 
biotinylation of protein A (biotin-EpA), the biotin-to-protein ratio (B/P) was not 
measured as it was assumed that EpA without biotin would not be captured by surface 
immobilized streptavidin.  In the case of the hetero-bifunctional labeling, the B/P could 
be inferred from the dye labeling result.  Because the biotin-PEG4-NHS has a diffusion 
coefficient ~25% faster than cy3-NHS and the NHS reactivities were assumed to be 
equivalent, the B/P should be greater than D/P for the simultaneous bifunctional labeling 
of proteins.  For bifunctional labeled proteins, rabbit antigoat (biotin-anti-GtIgG-cy3) was 
measured to have a D/P of 4.2 and protein A (biotin-EpA-cy3) had a D/P of 3.4.  The 
variation in molecule-to-molecule intensities using TIRF imaging was quite large in some 
cases (~30%).  This large variation in spot-to-spot intensity suggests there was a 
distribution in the number of fluorescent labels carried by each protein.  Because of the 
labeling variation and complicated photo-physics of multilabeled proteins,
52
 single-
molecule imaging is incapable of resolving multiple bound proteins to a single capture 
site based on individual spot intensities.  Although streptavidin, IgG, and protein A are 
multivalent, the measured capture activities of these surface immobilized proteins are 





4.3.2 Surface Preparation and Streptavidin Immobilization 
 Immunoassays 
The heterogeneous PEG functionalized surfaces were prepared by reacting a 
solution containing a mixture of dilute biotin-PEG48-amine and a much higher 
concentration of diluent mPEG16-amine with GOPTS-modified glass slides.  A PEG 
functionalization of the surface was chosen for its ability to reduce the nonspecific 
adsorption of biomolecules, while providing an inert layer where interfacially tethered 
proteins would be able to maintain a native-like structure and activity.
55-57
 In the previous 
chapter, it was shown that by diluting biotin-PEG-amine into an mPEG-amine 
monolayer, the density of biotin conjugation sites on glass surfaces is controllable.  The 
use of the well-developed and stable biotin-streptavidin interaction provided a generic, 
yet highly specific means to further immobilize any biotin-conjugated biomolecule 
through interfacially tethered streptavidin intermediates.
34
 The properties exhibited by the 
prepared PEG surfaces were previously characterized and discussed in the previous 
chapter.  The mPEG-modified surfaces without PEG-biotin tethers exhibited low levels 
(2.9  0.7  10-15 mols/m2) of nonspecifically adsorbed cy3-streptavidin, while increasing 
the ratio of surface immobilized biotin-PEG-amine-to-mPEG-amine resulted in a 
monotonic rise in the concentration of specifically immobilized cy3-streptavidin.  By 
preparing PEG modified surface with low conjugation site densities (≤ 2.9  10-12 
mols/m
2
), individual immobilized proteins could be easily resolved within the diffraction 
limits of optical microscopy allowing individual protein-protein interactions to be 
observed and quantified.  
In our previous work, it was observed that the interfacially associated biotin- 
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streptavidin complex was an extremely stable interaction.  Demonstrated in Figure 4.3, 
there was little observable dissociation (<20%) of the bound biotin-streptavidin complex 
during a 60 hour wash period, so that surface-bound biotin-streptavidin molecules were 
found to be irreversible on the time scales ≤ 24 h.27,34,58 The irreversible nature of the 
interaction was exploited in this experiment to investigate the activities of a variety of 
ligand-protein-receptor interactions intermediately tethered to a PEG-modified surface  





exhibits for biotin requires a minimal concentration of streptavidin to completely saturate 
a low-density of surface immobilized biotin conjugation sites. At such low concentrations 
(200 pM), cy3-streptavidin was found to exhibit minimal nonspecific adsorption (2.9 ± 
0.7  10-15 mols/m2) to mPEG-modified glass slides, as discussed in the previous chapter.  
As a result, the specific interactions accounted for 0.99996 of the total observed binding 
events on modified slides containing a low (≤ 7.2  10-13 mols/m2) density of biotin 
conjugation-sites.  By locating the positions of discretely immobilized cy3-streptavidin 
molecules on a modified glass surface using TIRF microscopy, all successively observed 
protein-protein interactions could be colocalized to known streptavidin locations, 
allowing specific and nonspecific surface interactions to be discriminated from each 
other.  The use of colocalization avoids the need to eliminate all nonspecific protein-
surface interactions for the subsequent investigation of protein-protein interactions, as the 





Figure 4.3: Washing of cy3-streptavidin from a 750 g/mol 
mPEG surface containing a low density of 2000 g/mol biotin-
PEG conjugation sites.  After ~60 hr >90% of the streptavidin 
population remained strongly immobilized. 
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4.3.3 Testing Capture Efficiency of Immobilized Antibodies 
Figure 4.4 illustrates the sequential association of cy3-streptavidin, biotin-anti-
GtIgG-cy3, and GtIgG–cy3 onto the biotin containing PEG surfaces.  Prior to the 
injection of each protein, the cy3- labels associated with the previously-immobilized 
capture biomolecules were photobleached by exposing the conjugated slides with 12 mW 
laser light until no observable fluorescent spots remained (~15 minutes).  The sequential 
deposition of each protein layer was then monitored by intermittently imaging the sample 
over the duration (180 minutes) of the accumulation experiment.  By collecting an image 
every 10 minutes, at 150 msecond integration periods, and 1 mW laser power, the 
accumulation of protein was observed over several hours with negligible photobleaching 
of the cy3-conjugated fluorescent labels.  At 1 mW of continuous 532 nm laser power, 
the time constant of complete photobleaching for a protein modified with an average of 
4.4 ± 0.2 cy3- labels was measured in Chapter 2 to be τPB ≈ 190 seconds.  For a labeled-
biomolecule present for an entire 180 minutes accumulation/wash, the conjugated 
fluorescent dyes would have been exposed to 2.7 s of 532 nm laser radiation.  As a result 
the probability of a false negative occurring as a result of photobleaching was small (< 
0.015).   
Following the injection of 75 ng/mL (500pM) biotin-anti-GtIgG-cy3 to a 
photobleached streptavidin-modified surface, antibody slowly accumulated, reaching a 
maximum in ~120 minutes.  Any weakly associated biotin-anti-GtIgG-cy3 was then 
removed by rinsing with PBS (0.1% Tween 20) for an additional 60 minutes, as shown in 
Figure 4.5.  Following the accumulation and rinse period, 5 images where then collected 




Figure 4.4: Heterogeneous sandwich assay and colocalization: (a) capture of 
cy3-streptavidin by surface immobilized biotin sites, (b) image and 
photobleach cy3-streptavidin, (c) capture of biotin-anti-IgG-cy3 by 
photobleached streptavidin, (d) image and photobleach biotin-anti-GtIgG-cy3, 











Figure 4.5: Accumulation and wash of 500 pM biotin-anti-
GtIgG-cy3 to surface immobilized streptavidin.  
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then co-added in order to average out intensity fluctuations.  The population of surface-
associated biotin-anti-GtIgG-cy3 molecules had an average fluorescence intensity of 
biotin-anti-GtIgG-cy3 = 326 photoelectron counts with a variation in spot-to-spot intensity 
counts, σbiotin-anti-GtIgG-cy3 = 38 photoelectrons.  The variation in the intensity between 
individual biotin-anti-GtIgG-cy3 spots likely arises from a distribution of labels carried 
by each biomolecule (see Figure 4.2).  
On average, the immobilized surface concentration of the streptavidin-capture 
sites was measured to be 3 (± 1)  10-13 mol/m2, which was well within the resolution 
limits (≤2  10-12 mol/m2) of imaging discrete single molecules using TIRF microscopy.  
The ~30% variation in immobilized streptavidin from slide-to-slide made comparing 
absolute protein surface concentrations from experiment-to-experiment irrelevant; as a 
result, all values reported in the following experiments are in terms of fractional activities 
of surface-bound proteins and not surface concentrations.  The colocalization of cy3-
streptavidn with biotin-anit-GtIgG-cy3 (Figure 4.6) revealed that only 8 ± 2 % of the total 
streptavidin population was able to capture biotin-anit-GtIgG-cy3 molecules; however, 
because of the small chance of random spot overlap, ≤ 2%, depending on streptavidin 
surface concentration, this value is an upper bound on the activity.  Considering the 
degree of biotin labeling (B/P ~ 4) and the concentration of anti-GtIgG (500 pM) 
injected, the streptavidin capture surface was exposed to an effective biotin concentration 
>2  105 times Kd, which should have been an adequate concentration to saturate all 
available streptavidin binding sites in the given time. 
The low capture efficiency exhibited by streptavidin capture surfaces for 




Figure 4.6: Steptavidin capture efficiency: (a) The locations of 
individual cy3-streptavidin molecule captured by surface immobilized 
biotin sites, (b) the location of individual biotin-anti-GtIgG-cy3 
molecules strongly adsorbed to the streptavidin modified surface, and (c) 
colocalized streptavidin (blue circles) and anti-IgG (black dots).  
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modified surfaces, it has been hypothesized that a single tetrameric streptavidin molecule 
could be immobilized through multiple biotins within a close proximity.
26
 This would 
render the remaining capture sites within a single streptavidin incapable of subsequently 
capturing and immobilizing additional biotinylated-proteins.  Given the extremely low 
surface concentration of biotin on the surfaces in this experiment, it is highly improbable 
that any streptavidin molecule is immobilized to the surface through more than one 
biotin.
26,28
 This fact suggests that the decrease in observed activity is not the result of the 
remaining binding sites of the immobilized streptavidin molecule being occupied by 
surface tethered biotin.  Another possibility may have resulted from some of the active 
sites on streptavidin being hindered by the surrounding surface; however, the long PEG 
(2000 MW) tether, through which the streptavidin was immobilized, should have allowed 
mobility above the surface.  If the PEG tether allows streptavidin to have dynamic motion 
above the surface, this should allow accessibility to the remaining biotin binding sites; 
however, as demonstrated by Figure 4.7, the capture of biotin-anti-GtIgG by surface 
immobilized streptavidin is not efficient, which implies the conformational mobility of 
the tethered streptavidin is limited.
59
 It is likely that the tethered streptavidin is also 
adsorbed to the modified interface through protein-surface interactions.  These 
interactions may have induced structural changes that disrupted the remaining active 
domains rendering them incapable of capturing additional biotin molecules.  
After the colocalization of the observed biotin-anti-GtIgG-cy3 events with known 
streptavidin locations, two populations of immobilized CAbs were revealed.  On average, 
36 ± 2% of the biotin-anti-GtIgG-cy3 population is associated (colocalized) with a 







Figure 4.7: Sequential capture of streptavidin, anti-GtIgG, and GtIgG: (a) 
located individual cy3-steptavidin molecules, (b) located individual biotin-
anti-GtIgG-cy3 molecules, (c) located individual GtIgG-cy3 molecules, and 
(d) colocalized events: (red circles) biotin-anti-GtIgG-cy3 molecules 
colocalized with cy3-streptavidin, (blue circles) anti-GtIgG passively 
adsorbed (not colocalized), and (black dots) GtIgG-cy3 molecules.    
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modified surface, but not tethered through streptavidin.  The capture efficiency of CAbs 
immobilized to surfaces through both streptavidin intermediates (PABC) and passive 
adsorption techniques has previously been reported;
11
 however, it becomes clear from the 
single molecule results that the heterogeneity of a capture surface increases as the 
complexity of the protein-scaffold layer increases, as illustrated in Figure 4.7.   In such 
cases where intermediate tether proteins are employed, the apparent capture efficiency of 
a CAb modified surface will represent an average of the heterogeneity of each 
contributing protein-protein interaction.  To better understand how the two populations of  
CAbs contribute to the total observed capture capacity of a surface, a model antigen 
(GtIgG-cy3) was injected over the anti-GtIgG-conjugated capture surfaces, accumulated, 
rinsed, and imaged.   
Individual interfacially adsorbed GtIgG-cy3 molecules had an average fluorescent 
intensity of GtIgG-cy3 =353 photoelectron counts with a variation in spot-to-spot intensity 
of σGtIgG-cy3 = 25 photoelectrons counts (see Figure 4.2).  When examining the 
colocalized events (Figure 4.7), 26 ± 1% of the streptavidin-biotin-anti-GtIgG complexes 
captured GtIgG-cy3 biomolecules, where in contrast, only 14 ± 4% of the passively 
adsorbed biotin-anti-GtIgG population captured GtIgG-cy3 molecules.  The total 
apparent capture activity of the surface (an average of the two antibody populations) is 18 
± 8%.  The activities of PoAbs immobilized to polystyrene surfaces using the PABC 
were previously measured to be 32 ± 27%, compared to 22 ± 3 % for passively adsorbed 
PoAbs, which agrees quite well with the single-molecule measurements.
11
 Although PEG 
functionalization was previously reported to help interfacially immobilized proteins 
maintain activity,
60
 the 750 g/mol PEG surface modification used to dilute the biotin 
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tethers in these experiments do not appear to significantly improve the activity of surface 
immobilized streptavidin or polyclonal CAbs in comparison to polystyrene surfaces. 
From these experiments, it is clear that the total apparent capture activity 
measured for a surface prepared by the PABC method is actually dominated by a 
population of passively adsorbed CAbs, which may explain the large standard deviations 
in activities previously reported for PABC methods.  In this research, it is evident that 
CAbs immobilized to surfaces through intermediate streptavidin molecules are nearly 2 
times more active compared to passively adsorbed CAbs, which may be explained by a 
protein cushion effect.  As a protein becomes further away from underlying surface 
functionality on an intermediate protein tether, interactions with the underlying 
glass/PEG surface are shielded, allowing the protein to maintain secondary and tertiary 
structures that may help preserve a more native-like activity.  Although the antibodies 
immobilized through streptavidin intermediates exhibited ~1.8 times greater capture 
activity compared to passively adsorbed antibodies, the total apparent activity derived 
from the streptavidin-biotin-anti-GtIgG (PABC) capture antibodies was ~5 fold lower 
than that from the passively adsorbed CAbs.  The extremely low efficiency (7.8 ± 0.2%) 
of surface immobilized streptavidin for immobilizing biotinylated-CAbs dominated the 
small total observed antigen capture activity of the initial streptavidin sites (2.1 ± 0.4%). 
 
4.3.4 Oriented Antibody Immobilization through Protein A 
The low capture yields associated with CAb immobilized using the passive 
adsorption or PABC techniques were likely influenced by the orientation of the 
biomolecules with respect to the interface.
20
 Given the asymmetric structure of an 
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antibody, the orientation of a surface immobilized CAb might result in one or both Fab  
domain(s) being inaccessible to target antigens in solution.  In the case of biotinylated-
antibodies, the biotin tags were conjugated using N-hydroxysuccinimidyl (NHS) ester 
chemistry through randomly accessible ε-amines distributed throughout the entire 
antibody molecule. The capture of the biotinylated-CAb by a surface immobilized 
streptavidin likely resulted in a distribution of random orientations of the antibody with 
respect to the interface, as illustrated in Figure 4.8.  Considering ~74% of the 
streptavidin-biotin-anti-GtIgG complexes were rendered inactive once immobilized to an 
interface, the orientation of the capture antibody must be factor. 
Protein A is a cell wall component of the Staphylococcus aureus and is well 
known to bind the Fc region of IgG antibodies.
61
 E. coli protein A (EpA), which 
functions similarly to native protein A, has four binding domains and was chosen to be 
used in this experiment because of its high affinity for rabbit derived IgG molecules (our 
capture antibody) and poorer affinity for goat derived IgG, our model antigen.
62
 
Illustrated in Figure 4.9, biotin-EpA-cy3 and anti-GtIgG-cy3 were sequentially injected 
onto a streptavidin-modified surface using a two-step immobilization procedure. 
Solutions containing 10 ng/ml (250 pM) of biotin-EpA-cy3 in PBS, 75 ng/ml (500 pM) 
of anti-GtIgG-cy3 in PBS, and 75 ng/mL (500 pM) of GtIgG-cy3 in PBS were 
sequentially captured and localized using the previously described methods (see above).    
Because of the extremely low efficiencies associated with the two-step method (see 
below), a much higher density (~4  10-12 mol/m2) streptavidin capture surface was 
needed to accumulate sufficient protein to acquire statistically relevant data on the second 





Figure 4.8: The immobilization strategies used. (a) Random 
immobilization of biotin-anti-IgG with an average of four biotin labels 
per protein to a streptavidin conjugated surface. (b) Capture of solution 









Figure 4.9: Two-Step capture-antibody immobilization using 
protein A: (a) Random immobilization of biotin-EpA with an 
average of three biotin labels per protein to a streptavidin 
conjugated surface. (b) Protein A capturing the Fc domain of 
anti-GtIgG-cy3. (c) The binding of solution GtIgG molecules 






upper threshold (~2  10-12 mol/m2) for resolving discrete fluorescent spots using optical 
based microscopy; therefore, the two-step immobilization of biotin-EpA-cy3 and anti-
GtIgG-cy3 experiment was not colocalized with the initial streptavidin capture sites.  The 
values reported for this experiment include the entire population of streptavidin-bound 
and passively adsorbed EpA population.  However, the fraction of streptavidin-bound 
EpA should be higher than for the CAb results above because of the ~5-fold greater 
biotin capture site density. 
The surface adsorbed population of biotin-EpA-cy3 had an average fluorescence 
intensity of biotin-EpA-cy3 = 378 photoelectron counts with a variation in spot-to-spot 
intensity of σbiotin-EpA-cy3 = 25 photoelectrons.  The fluorescent intensity and spot-to-spot 
intensity variation for the subsequently immobilized anti-GtIgG-cy3 and GtIgG-cy3 were 
consistent with results reported above (see Figure 4.4).  On average, 3 ± 1  10-13 mol/m2 
of biotin-EpA-cy3 were bound to the streptavidin-modified surface after the 
accumulation/rinse cycle, which was well within the limits of resolving individual 
molecules using TIRF imaging techniques.  Of the total immobilized biotin-EpA-cy3 
population, 5.4 ± 0.5% was able to capture an Fc domain of anti-GtIgG-cy3 molecules, 
forming a surface immobilized biotin-EpA-RbAbGt-cy3 complex.  The colocalization of 
these complexes with subsequently bound GtIgG-cy3 revealed that 33 ± 2% of the biotin-
EpA-anti-GtIgG-cy3 complexes captures a GtIgG-cy3 molecule.  By immobilizing a 
CAb through an EpA molecule to a surface using the two-step method, there was a small, 
but distinguishable, ≥ 8%, increase in the activity of protein A immobilized CAbs 
compared to biotinylated antibodies immobilized randomly to streptavidin.  Despite this 
increase in activity for CAbs sequentially immobilized through EpA, the total apparent 
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surface activity exhibited by the two-step formation of the EpA-anti-GtIgG complex was 
extremely low (~0.1%) due to the poor efficiency exhibited by EpA (5.4%) for capturing 
the Fc domain of an IgG.  The inefficient capture efficency could be the result of 
inaccessible Fc binding domains or deactivation of those binding domains upon 
immobilization.  
In order to exercise better control over the orientation of CAbs and increase the 
antibody capture activity of a EpA, biotin-EpA and anti-GtIgG-cy3 were pre-associated 
as a (biotin-[EpA/anti-GtIgG]-cy3) chimeric complex in solution and then immobilized to 
a low density (~5  10-13 mol/m2) streptavidin-modified surface, as illustrated in Figure 
4.10.  A solution containing 6 μg/ml (125 nM) biotin-EpA and 38 μg/ml (250 nM) anti-
GtIgG-cy3 was pre-equilibrated for 1 hour.   Anti-GtIgG-cy3 was present at a much 
higher concentration in solution to minimize the probability of an unconjugated EpA 
being immobilized to streptavidin capture sites.  After the incubation period, the solution 
was diluted by a factor of 500 in PBS buffer and then injected onto the low-density 
streptavidin modified surface.   
Because anti-GtIgG-cy3 was not biotinylated, all anti-GtIgG-cy3 locations that 
colocalized the original cy3-SA locations were assumed to be associated through a biotin-
EpA intermediate.  To test this assumption, the fraction of immobilized streptavidin that 
colocalized with anti-GtIgG-cy3 was measured and found to be 7.9 ± 0.2%, which agrees 
with the previously observed capture efficiency of streptavidin for biotinylated antibodies 
(8 ± 2%) and suggests that the anti-GtIgG-cy3 were indeed associated with biotinylated 
EpA.  Following the immobilization of the chimeric complex, 75 ng/ml (500 pM) of  




Figure 4.10: One-step chimeric protein A/capture-antibody 
immobilization: (a) Preassociation of 125 nM biotin-EpA and 
250 nM antiGtIgG-cy3 ex situ. (b) The capture of biotinylated-
chimeric complex by surface immobilized streptavidin.  (c) The 
binding of solution GtIgG molecules to oriented surface 







revealed that 54 ± 2% of the total SA-biotin-[EpA/anti-GtIgG]-cy3 conjugates captured  
GtIgG-cy3 molecules.  The one-step chimeric EpA/Ab method was ~30 times more 
active at capturing Ag molecules compared to the two-step sequential surface 
immobilization of EpA and CAb due to the poor efficiency (5.4%) of the immobilized 
EpA binding to a CAb binding site.  It is important to note that the EpA used in this 
experiment had four binding domains.  It is possible that with the high concentration of 
anti-GtIgG present during the pre-association period for the chimeric complex, that each 
EpA could have been associated with multiple anti-GtIgG molecules.  It may very well 
be that the size and multivalency of the formed complex was responsible for the 30% 
increase in observed antibody activity and not necessarily the orientation of an individual 
anti-GtIgG through the biotin-EpA intermediate.  Regardless, this result clearly 
demonstrates the effectiveness of immobilizing a pre-associated Fc binding protein (A, 
G, A/G)-CAb complex to interfaces.  The efficiency of the streptavidin for capturing the 
biotin-chimeric complex remains small (7.9 ± 0.2%), leading to an overall apparent 
capture efficiency of 4.2 ± 0.9% relative to the immobilized streptavidin population.   
 
4.4 Discussion 
The activity of solid phase immunoassays was characterized for a variety of CAb 
immobilization strategies commonly used in “sandwich-type” immunoassays using 
single-molecule TIRF imaging techniques, as summarized in Figure 4.11.  The PABC 
method was employed as a generic means to immobilize any biotin-conjugated protein to 










Figure 4.11: Tabulated activity associated with each immobilization scheme.  
‡ This value assumes the efficiency of streptavidin capturing biotin-EpA is equivalent to biotin-   
[EpA/anti-GtIgG] (7.9 ± 0.2%).  
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controllable, while minimizing the nonspecific adsorption of subsequently added 
proteins.  The activity of anti-GtIgG was measured and compared for four immobilization 
strategies: (i) passive adsorption to the mPEG surface, (ii) immobilization through 
biotinylation to streptavidin capture sites, (iii) a two-step oriented immobilization through 
streptavidin-EpA intermediate, and (iv) a one-step immobilization to streptavidin as a 
chimeric [EpA/anti-GtIgG] complex.   In all cases, the bioaffinity tethering using the 
streptavidin intermediate resulted in 2- to nearly 4-fold increase in observed CAb activity 
compared to a passivly adsorbed antibody.   
The one-step immobilization of the chimeric EpA-CAb complex, resulting in ~54 
% antigen capture activity, maintained the highest activity of any immobilized anti-
GtIgG.  In all cases utilizing indirect immobilization through a streptavidin intermediate, 
the overall activity arising from the PABC-immobilized antibodies was less than half of 
the passively adsorbed antibodies.  This was due to the poor efficency (~8 %) of surface 
immobilized streptavidin molecules capturing biotinylated-proteins (both antibodies and 
protein A), which resulted in low PABC-bound CAb surface concentrations.  Although 
only ~14% of passively adsorbed CAbs remain active, the magnitude of this population 
dominates the observed activity.  From these experiments, it becomes obvious that 
protein-protein interactions at interfaces can exhibit poor capture efficiencies; therefore, 
the compounded activity of multistep immobilization strategies can suffer from poor 
yields. As a result, the efficiency of the scaffolding that supports CAb for solid phase 
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5.1 Future Perspectives 
The goal of this research was to develop a method capable of overcoming the 
limitations, discussed in Chapter 1, associated with high-density capture assays.  
Transport-limited binding rates, nonreversible interfacial kinetics, and poor capture 
efficiencies for surface immobilized protein-receptor molecules, in theory, can be 
overcome with decreased capture site densities on a measurement surface.  In this work 
single-molecule total internal refection fluorescence (TIRF) imaging was employed to 
monitor discrete protein-surface, protein-hapten, and protein-protein interactions at a 
glass-water interface.  While decreasing the density of receptor sites reduced transport 
limitations and prevented bivalent interactions between adjacent receptor sites, many new 
challenges were revealed and required attention in order to accurately characterize the 
interfacial processes governing protein recognition at surfaces. 
The primary challenge associated with imaging individual ligand-receptor 
interactions at glass-water interfaces is the ability to discern specific (ligand-receptor) 
from nonspecific (ligand-surface) interactions.  Although this task can be addressed in 
multiples ways, preventing the nonspecific adsorption of proteins to the capture surface is 
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the most ideal method.  Discussed in Chapter 3, the optimal surface density of 
immobilized receptor molecules spans the range of ~60 to 100 amol/cm
2
.  This density 
corresponds to a large enough surface population of receptor sites to obtain statistically 
valid observations, while the binding sites are well resolvable within the diffraction limits 
of optical microscopy.  Ideally, the surface passivation technique should prevent the 
nonspecific adsorption of proteins at much lower surface concentrations than specific 
interactions (<<60 amol/cm
2
); however, in many cases, nonspecific interactions account 
for significant fractions (>50%) of the total observed interfacial events.  This requires 
additional filtering techniques, such as colocalization, in order to discern specific from 
nonspecific interactions. 
In this research, grafted poly(ethylene glycol) (PEG) monolayers were used to 
prevent the nonspecific adsorption of biomolecules to glass surfaces, while providing a 
means to control the surface density of biotin conjugation sites.  In Chapter 2, the grafting 
of mPEG-amine molecules to epoxide-modified glass slides resulted in surfaces that were 
adequately resistant to the nonspecific adsorption of IgG.  From a solution containing 1 
nM anti-biotin, ~20 amol/cm
2
 of IgG remained strongly bound to the 750 g/mol mPEG 
monolayer after a 4 hour accumulation/wash period, whereas only ~1 amol/cm
2
 remained 
adsorbed to the 2000 g/mol mPEG monolayer.  In both cases, these surfaces are highly 
resistant to the adsorption of IgG at the macroscopic level, where the nonspecifically 
adsorbed IgG is less than 10
-6
 of a monolayer for the 750 g/mol mPEG surface; however, 
this coverage corresponds to high background signals (>50 molecules/frame) with respect 
to imaging individual molecules on a surface.  From the work conducted in Chapter 2, it 
was determined that defect sites within the deposited PEG monolayers are always present 
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at the molecular level (>1 amol/cm
2
), and all of the mPEG surface modifications prepared 
in this work were insufficient at eliminating all nonspecific protein-surface adsorption. 
In Chapter 3, the density of biotin conjugation sites was shown to be controllable 
by diluting in a low concentration biotin-PEG into a 750 g/mol mPEG monolayer.  The 
concentration of tetrameric streptavidin molecules that strongly bound to these surfaces 
increased linearly with respect to the dilution ratio of mPEG to biotin-PEG composing 
the reaction solutions.  Although the 2000 g/mol mPEG monolayers produced in Chapter 
2 exhibited a much higher resistance to the nonspecific adsorption of IgG, a mixed 
monolayer of 2000 g/mol biotin-PEG and 2000 g/mol mPEG resulted in uncontrollable 
conjugation site densities and poor streptavidin surface conjugation.  It is believed that 
this outcome was the result of the biotin conjugation sites being inaccessibly 
buried/hindered by the equivalently sized diluent mPEG layer.  In contrast, streptavidin 
bound at a controllable density to a longer chain (2000 g/mol) biotin-PEG, diluted into a 
shorter chain (750 g/mol) mPEG monolayer.  It was demonstrated that the density of 
biotin sites was controllable over a range of ~40 to 140 amol/cm
2
, where the optimal site 
density for single-molecule imaging is within ~60 to 100 amol/cm
2.  While this “optimal 
density” of surface sites for imaging could be achieved, the population of nonspecifically 
adsorbed IgG molecules, resulting from a 1 nM solution of antibody, accounts for >20% 
of the total observed surface events at such densities.  Thus, the receptor-modified 
surfaces can only support measurement of analyte (IgG) concentrations that are much 
lower than 1 nM or otherwise require additional image processing in order to discern 
nonspecific from specific interactions.  





) nonspecific adsorption of streptavidin, this intermediate protein linker could 
be used to quantify the surface biotin-PEG density as described above.  Beyond this step, 
colocalization was used in Chapter 4 as a means to overcome all nonspecific protein-
surface interactions.  By exploiting the ability to permanently photobleach the fluorescent 
cy3 molecule, cy3-labeled protein-ligands were sequentially captured and colocalized to 
each previously located receptor molecule.  In Chapter 4, capture antibodies (anti-IgG) 
were immobilized using four techniques and then exposed to antigen (IgG): (i) passive 
immobilization, (ii) directed immobilization to streptavidin, (iii) oriented two-step 
sequential immobilization to protein A, and (iv) a one-step immobilization as a CAb-
protein A chimeric complex.  The activities of each capture step were calculated through 
colocalization of bound proteins and then compared.  
The work presented within this dissertation resulted in two important conclusions.  
In Chapter 4, it is evident that the capture efficiency of proteins directly immobilized to a 
PEG modified surface is extremely low.  Although it is possible to increase the capture 
efficiency of a protein-receptor molecule by immobilizing the receptor molecule in a 
more oriented manner through the sequential build up of complex protein scaffolding, the 
capture activities of each additional layer are compounded and often result in total 
apparent observed activities that are <5%.  In many cases, it is not uncommon for 
nonspecific interactions to account for >90% of the total observed events. The PEG-
modified surfaces developed in this dissertation were unable to completely overcome 
nonspecific adsorption at the molecular level, which made resolving specific interactions 
from nonspecific interactions a difficult task.  In addition, the low capture activities 
associated with surface immobilized receptor sites resulted in convoluted and statistically 
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limited information about the measured surface interactions.  The high backgrounds and 
low sensitivity associated with single-molecule fluorescence imaging of discrete ligand-
receptor interactions suggests that the single-molecule TIRF methodology presented 
within this dissertation is an impractical tool for immunodiagnostic measurements.     
Although this research did not produce a selective and highly sensitive single-
molecule immunoassay method, a better understanding of the fundamental interactions 
that govern immunoassays at the molecular level was achieved.  All of the interfacial 
protein-protein and protein-hapten interactions observed in this research revealed little-
to-no measureable reversibility over the timescale of days.  The strong ligand-receptor 
interactions measured were not the consequence of bivalent interactions or recapture 
processes, but the result of a single-ligand bound to a single-receptor.  Although little 
kinetic information can be gained from such interactions, the signal measured in 
“sandwich” assays is likely not influenced by the dissociation of subsequently deposited 
protein layers.  
In addition, all of the surface immobilized proteins studied within this research 
exhibited much lower capture activities than theoretically achievable.  Although larger 
IgG receptor-molecules appeared to be more robust once immobilized to a surface in 
comparison to the smaller streptavidin and protein A receptor-molecules used in these 
experiments, the deposition method and orientation of the immobilized receptor-protein 
was the most influential factors in maintaining high surface activity.  Depending on the 
capture protein being immobilized, the immobilization method should carefully be 
considered in order to maximize the sensitivity of the measurement surface.  For 
example, a surface-immobilized protein A will potentially capture an IgG molecule 
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through the Fc fragment with one or both Fab fragments oriented away from the surface, 
as discussed in Chapter 4.  The capture of an IgG by a surface immobilized protein A is 
an inefficient process; however, the apparent capture efficiency of a receptor surface can 
be increased by nearly 30-times when the capture antibody is deposited as a one-step 
protein A-IgG chimeric complex.  It is clear that the sensitivity of the immunodiagnostic 
measurement is greatly influenced by the method in which the CAbs are deposited, and 
small differences in methodology can result in large changes in sensitivity. The protein 
scaffolding used and means of deposition for each protein layer needs to be carefully 
considered in order to achieve maximum signal and high sensitivity from a capture 
surface. 
 
 
